International General Insurance (IGIC) 6-K 20 Oct 21 2021 Q2 Interim Condensed Consolidated Financial Statements Financial data

Document And Entity Information

Document And Entity Information	6 Months Ended
	Jun. 30, 2021
Document Information Line Items
Entity Registrant Name	International General Insurance Holdings Ltd.
Document Type	6-K
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001794338
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Entity File Number	001-39255

Interim Condensed Consolidated

Interim Condensed Consolidated Statement of Financial Position - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 180,134	$ 133,439
Term deposits	185,816	172,212
Insurance receivables	188,770	166,605
Investments	456,497	438,087
Investments in associates	11,841	11,583
Reinsurance share of outstanding claims	186,563	187,485
Reinsurance share of unearned premiums	66,443	50,077
Deferred excess of loss premiums	5,351	17,095
Deferred policy acquisition costs	61,083	55,172
Other assets	11,827	9,562
Investment properties	18,788	20,012
Property, premises and equipment	12,928	13,168
Intangible assets	5,458	4,710
TOTAL ASSETS	1,391,499	1,279,207
LIABILITIES
Gross outstanding claims	545,101	492,255
Gross unearned premiums	312,511	277,268
Insurance payables	93,585	83,461
Other liabilities	20,564	20,491
Derivative financial liability	17,423	13,628
Deferred tax liabilities	173	55
Unearned commissions	11,910	11,038
TOTAL LIABILITIES	1,001,267	898,196
EQUITY
Common shares at par value	489	486
Share premium	158,453	157,677
Foreign currency translation reserve	(310)	(349)
Fair value reserve	16,425	18,160
Retained earnings	215,175	205,037
TOTAL EQUITY	390,232	381,011
TOTAL EQUITY AND LIABILITIES	$ 1,391,499	$ 1,279,207

Interim Condensed Consolidate_2

Interim Condensed Consolidated Statement of Income (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	[1]
Profit or loss [abstract]
Gross written premiums	$ 266,772	$ 236,501
Reinsurers’ share of insurance premiums	(80,078)	(65,879)
Net written premiums	186,694	170,622
Change in unearned premiums	(35,243)	(52,304)
Reinsurers’ share of change in unearned premiums	16,366	17,932
Net change in unearned premiums	(18,877)	(34,372)
Net premiums earned	167,817	136,250
Claims and claim adjustment expenses	(102,763)	(94,611)
Reinsurers’ share of claims	12,897	30,324
Net claims and claim adjustment expenses	(89,866)	(64,287)
Commissions earned	9,643	8,217
Policy acquisition costs	(39,032)	(34,087)
Net policy acquisition expenses	(29,389)	(25,870)
Net underwriting results	48,562	46,093
General and administrative expenses	(29,284)	(22,423)
Net investment income	9,330	3,052
Share of profit (loss) from associates	258	(439)
Impairment loss on insurance receivables	(1,121)	(2,178)
Other revenues	1,021	117
Other expenses	(1,438)	(605)
Listing related costs		(3,366)
Change in fair value of derivative financial liability	(3,795)	3,347
Loss on foreign exchange	(3,175)	(8,658)
Profit before tax	20,358	14,940
Income tax	(1,932)	(433)
Profit for the period	$ 18,426	$ 14,507
Earnings per share
Basic and diluted earnings per share attributable to equity holders (in Dollars per share)	$ 0.38	$ 0.33
[1]	The consolidated financial statements for the six months ended 30 June 2020 have been restated as per note 2.

Interim Condensed Consolidate_3

Interim Condensed Consolidated Statement of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Interim Condensed Consolidated Statement of Comprehensive Income (Unaudited) [Abstract]
Profit for the period	$ 18,426	$ 14,507
Other comprehensive income to be reclassified to profit or loss in subsequent periods
Net change in fair value reserve during the period for bonds at fair value through other comprehensive income	(4,461)	5,654
Currency translation difference	39	(53)
Changes in allowance for expected credit losses transferred to interim condensed consolidated statement of income	32	65
Other comprehensive income which will not be reclassified to profit or loss in subsequent periods
Net change in fair value reserve during the period for equities at fair value through other comprehensive income	2,694	(3,561)
Other comprehensive (loss) income for the period	(1,696)	2,105
Total comprehensive income for the period	$ 16,730	$ 16,612

Interim Condensed Consolidate_4

Interim Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Statement of cash flows [abstract]
Profit for the period before tax	$ 20,358	$ 14,940
Adjustments for:
Impairment loss on insurance receivables	1,121	2,178
Loss on sale of premises and equipment	60
Depreciation	1,199	910
Amortization	672	213
Net share of (profit) loss from associates	(258)	439
Lease interest expense	91	49
Realized loss on sale of bonds at FVTOCI	321	113
Realized gain on sale of equities and mutual funds at FVTPL	(484)	(1,639)
Realized loss on sale of investment properties	1	41
Unrealized loss on investment properties	815	724
Expected credit loss on financial assets at FVOCI	32	65
Expected credit loss on financial assets at amortized cost		1
Unrealized (gain) loss on revaluation of financial assets at FVTPL	(2,128)	2,854
Share-based payment expense – restricted shares awards	779
Change in fair value of derivative financial liability	3,795	(3,347)	[1]
Loss on foreign exchange	3,175	8,658
Cash from operations before working capital changes	29,549	26,199
Term deposits	(13,604)	(25,281)
Insurance receivables	(24,954)	(65,485)
Purchase of investments	(86,820)	(129,507)
Proceeds from sale and maturity of investments	68,815	52,624
Reinsurance share of outstanding claims	922	636
Reinsurance share of unearned premiums	(16,366)	(17,932)
Deferred excess of loss premiums	11,744	10,847
Deferred policy acquisition costs	(5,911)	(9,347)
Other assets	(1,634)	(929)
Additions to investment properties	(23)	(44)
Proceeds from sale of investment properties	431	1,237
Gross outstanding claims	52,846	28,388
Gross unearned premiums	35,243	52,304
Insurance payables	10,124	22,165
Other liabilities	(804)	(2,608)
Unearned commissions	872	4,281
Income tax paid	(1,478)	(677)
Net cash from (used in) operating activities	58,952	(53,129)
Investing Activities
Acquisition of a subsidiary, net of cash acquired	(146)
Purchase of premises and equipment	(267)	(115)
Purchase of intangible assets	(1,420)	(6)
Net cash used in investing activities	(1,833)	(121)
Financing Activities
Cash injection in connection with Business Combination		120,821
Consideration paid to shareholders as deemed settlement for shares		(80,000)
Dividends paid	(8,288)
Lease liabilities payments	(339)	(318)
Net cash (used in) from financing activities	(8,627)	40,503
Net change in cash and cash equivalents	48,492	(12,747)
Net foreign exchange differences	(1,797)	(6,035)
Cash and cash equivalents at the beginning of the period	133,439	192,460
Cash and cash equivalents at the end of the period	$ 180,134	$ 173,678
[1]	The consolidated financial statements for the six months ended 30 June 2020 have been restated as per note 2.

Interim Condensed Consolidate_5

Interim Condensed Consolidated Statements of Changes In Equity (Unaudited) - USD ($) $ in Thousands	Issued share capital	Common shares at par value	Additional paid in capital	Share premium	Warrants	Treasury shares	Foreign currency translation reserve	Fair value reserve	Retained earnings	Total
Balance at Dec. 31, 2019	$ 143,376		$ 2,773			$ (20,103)	$ (333)	$ 4,274	$ 182,156	$ 312,143
Profit for the period									11,160	11,160
Other comprehensive income							(53)	2,158		2,105
Total comprehensive income							(53)	2,158	11,160	13,265
Issuance of shares in connection with Business Combination (note 19) - at par value of USD 0.01		484								484
Issuance of warrants in connection with Business Combination (note 19)					12,213					12,213
Consideration paid to shareholders as deemed settlement for shares (note 19)				(80,000)						(80,000)
Business Combination elimination adjustments (note 19)	(143,376)		(2,773)	234,225		20,103			(10)	108,169
Equity before restated		484		154,225	12,213		(386)	6,432	193,306	366,274
Impact of restatement (note 2)				3,003	(12,213)				3,347	(5,863)
Balance at Jun. 30, 2020		484		157,228			(386)	6,432	196,653	360,411
Balance at Dec. 31, 2020		486		157,677			(349)	18,160	205,037	381,011
Profit for the period									18,426	18,426
Other comprehensive income							39	(1,735)		(1,696)
Total comprehensive income							39	(1,735)	18,426	16,730
Issuance of restricted shares awards (note 11)		3		776						779
Cash dividends (note 12)									(8,288)	(8,288)
Balance at Jun. 30, 2021		$ 489		$ 158,453			$ (310)	$ 16,425	$ 215,175	$ 390,232

Corporate Information

Corporate Information	6 Months Ended
	Jun. 30, 2021
Disclosure Of Corporate Information [Abstract]
CORPORATE INFORMATION	1. CORPORATE INFORMATION International General Insurance Holdings Ltd. (“the Company”) is an exempted limited liability company registered and incorporated in Bermuda under the Companies Act of 1981 on 28 October 2019. The principal activities of the Company are to invest in companies engaged in the business of insurance and reinsurance. The Company’s registered office is at Clarendon House, 2 Church Street, Hamilton, HM11, Bermuda. On 17 March 2020, the definitive business agreement between International General Insurance Holdings Limited - Dubai (“IGI”) and Tiberius Acquisition Corp. (NASDAQ: TIBR) (“Tiberius”), a publicly traded special purpose acquisition company, and certain related parties, was effective. As a result of the completion of the Business Combination, the Company became a new public company listed on the Nasdaq Capital Market under the symbol “IGIC” and owned by the former stockholders of Tiberius and the former shareholders of IGI and each of IGI and Tiberius became the Company’s subsidiaries. The transaction is accounted for as a continuation of IGI. Under this method of accounting, while the Company is the legal acquirer of both IGI and Tiberius, IGI has been identified as the accounting acquirer of Tiberius for accounting purposes. This determination was primarily based on IGI comprising the ongoing operations of the combined company, IGI’s senior management comprising the senior management of the combined company, and the former owners and management of IGI having control of the Board of Directors of the Company following the consummation of the transaction by virtue of being able to appoint a majority of the directors of the combined company. As Tiberius does not meet the definition of a business as defined in IFRS 3 - Business Combinations (“IFRS 3”), the purchase of the shares of the former owners of Tiberius is not within the scope of IFRS 3 and is accounted for as a share-based payment transaction in accordance with IFRS 2 - Share-based payments (“IFRS 2”). Hence, the transaction was accounted for as the continuance of IGI with recognition of the identifiable assets acquired and the liabilities assumed of Tiberius at fair value. Operations prior to the transaction are those of IGI from an accounting point of view (note 19). The Company and its subsidiaries (together “the Group”) operate in Bermuda, United Kingdom, Jordan, Morocco, Malaysia, United Arab Emirates and the Cayman Islands. The interim condensed consolidated financial statements were authorized for issue in accordance with a resolution of the Board of Directors on 18 October 2021.

Basis of Preparation

Basis of Preparation	6 Months Ended
	Jun. 30, 2021
Disclosure of basis of preparation of financial statements [text block] [Abstract]
BASIS OF PREPARATION	2. BASIS OF PREPARATION The interim condensed consolidated financial statements for the six months ended 30 June 2021 have been prepared in accordance with IAS 34 - Interim Financial Reporting. The interim condensed consolidated financial statements have been presented in United States Dollars “USD” which is also the Group’s functional currency. All values are rounded to the nearest thousand (USD ’000), except when otherwise indicated. The interim condensed consolidated financial statements do not include all information and disclosures required in the annual financial statements and should be read in conjunction with the Group’s annual consolidated financial statements as at 31 December 2020. In addition, results for the six months ended 30 June 2021 are not necessarily indicative of the results that may be expected for the financial year ending 31 December 2021. The interim condensed consolidated financial statements are prepared on a going concern basis under the historical cost convention modified to include the measurement at fair value of financial assets and investment properties at fair value through profit or loss, and financial assets at fair value through other comprehensive income. financial assets measured at fair value through profit and loss include quoted funds, alternative investments and quoted equities. Financial assets at fair value through other comprehensive income include quoted and unquoted equities. On 30 January 2020, the World Health Organization declared the outbreak of coronavirus (“COVID-19”) to be a public health emergency of international concern. This coronavirus outbreak has severely restricted the level of economic activity around the world. In response to this coronavirus outbreak, the governments of many countries, states, cities and other geographic regions have taken preventative or protective actions, such as imposing restrictions on travel and business operations and advising or requiring individuals to limit or forego their time outside of their homes. Following measures announced by local governments in March 2020, the Company implemented aspects of the Group’s business continuity plan (BCP), specifically requiring staff at all levels and in all functions to work remotely wherever practicable, and to limit the need for gatherings of staff so far as possible. The Group’s IT facilities have ensured that all of the Group’s operations have been maintained allowing the Group to function as normal. The Company expects that these operational changes will continue to be required until all employees are allowed to return to their offices in accordance with local government advice. The full extent to which the COVID-19 pandemic may impact the Group’s results, operations or liquidity is uncertain. Management continues to monitor the impact that the COVID-19 pandemic has on the Group, the insurance industry and the economies in which the Group operates. The stress testing conducted periodically by management since the onset of the COVID-19 pandemic indicated that the impact of COVID-19 on the Group would be manageable and not give rise to a need for management actions to protect its regulatory capital position. The analysis and monitoring to date confirmed that the Group’s underwriting portfolio is not materially exposed to the classes of business which are largely impacted by COVID-19. This assessment is supported by the fact that as of June 30, 2021, management’s best estimates of the specific reserves in respect of COVID-19 related claims are not considered to be significant. The Group also writes professional indemnity coverage within the casualty line of business within our specialty long-tail segment which includes a portfolio of insurance brokers on which the Group has received notifications in respect of business interruption coverage. This portfolio is predominantly written on an excess layer basis with high attachment points and, although this portfolio accounts for the majority of the COVID-19 notifications received to date, the notifications to date are considered precautionary on the part of the broker. We are not exposed to those classes of insurance most directly impacted by COVID-19 (such as life, health, travel, contingent business interruption and event cancellation). In addition, although a number of business classes including property, engineering, and ports and terminals in our specialty short-tail segment provide business interruption coverage, this coverage requires underlying insured property damage or breakdown in order to trigger a loss. One small exception is limited exposure to hotels where business interruption cover has been provided on the basis of covering “murder, suicide, loss of attraction, human infectious & contagious diseases.” The Group is less likely to have exposure in this area because these coverages are heavily sub-limited and in most cases attach at a high excess. With respect to claims administration, the Group has not evidenced a discernible impact on the reporting and settlement of claims, as the third-party loss adjusters and other appointed experts, in conjunction with the Group’s inhouse claims function, have demonstrated an ability to adapt effectively to the virtual world in servicing claims. In addition, the combination of a modest allocation to equities and the high quality and diversified nature of the Group’s bonds and term deposits has resulted in a minor negative mark to market adjustment in its investment portfolio. However, a material fair value revaluation loss close to 5% and 9% from the previous year end was recorded against investment properties owned directly in Jordan and through associates in Lebanon, respectively, which is in line with the overall correction seen in the regional commercial real estate valuations post pandemic. Basis of consolidation The interim condensed consolidated financial statements comprise the financial statements of International General Insurance Holdings Ltd. and its subsidiaries as at 30 June 2021. Control is achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Specifically, the Group controls an investee if and only if the Group has: ● Power over the investee (i.e. existing rights that give it the current ability to direct the relevant activities of the investee) ● Exposure, or rights, to variable returns from its involvement with the investee, and ● The ability to use its power over the investee to affect its returns When the Group has less than a majority of the voting or similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee, including: ● The contractual arrangement with the other vote holders of the investee ● Rights arising from other contractual arrangements ● The Group’s voting rights and potential voting rights The Group re-assesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of the three elements of control. Consolidation of a subsidiary begins when the Group obtains control over the subsidiary and ceases when the Group loses control of the subsidiary. Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated statement of comprehensive income from the date the Group gains control until the date the Group ceases to control the subsidiary. When necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with the Group’s accounting policies. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to transactions between members of the Group are eliminated in full on consolidation. A change in the ownership interest of a subsidiary, without a change of control, is accounted for as an equity transaction. If the Group loses control over a subsidiary, it: ● Derecognizes the assets (including goodwill) and liabilities of the subsidiary; ● Derecognizes the carrying amount of any non-controlling interest; ● Derecognizes the cumulative translation differences, recorded in equity, if any; ● Recognizes the fair value of the consideration received; ● Recognizes the fair value of any investment retained; ● Recognizes any surplus or deficit in profit or loss; and ● Reclassifies the parent’s share of components previously recognised in other comprehensive income to profit or loss or retained earnings, as appropriate. Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Group obtains control, and continue to be consolidated until the date that such control ceases. The Group has the following subsidiaries and branches: Country of incorporation Activity Ownership 30 June 2021 31 December International General Insurance Holdings Limited United Arab Emirates Reinsurance and insurance 100 % 100 % Tiberius Acquisition Corporation United States of America Special purpose acquisition company 100 % 100 % The following entities are wholly owned by the subsidiary International General Insurance Holdings Limited: I.G.I Underwriting /Jordan “Exempted” Jordan Underwriting agency 100 % 100 % North Star Underwriting Limited United Kingdom Underwriting agency 100 % 100 % International General Insurance Co. Ltd. Bermuda Reinsurance and insurance 100 % 100 % The following entities are wholly owned subsidiaries and branches by International General Insurance Co. Ltd. Bermuda: Subsidiaries: International General Insurance Company (UK) Limited United Kingdom Reinsurance and insurance 100 % 100 % International General Insurance Company (Dubai) Ltd. United Arab Emirates Insurance intermediation and insurance management 100 % 100 % International General Insurance Company (Europe) SE* Malta Reinsurance and insurance 100 % - Specialty Malls Investment Company Jordan Real estate properties development and lease 100 % 100 % IGI Services Ltd Cayman Islands Owning and chartering aircraft 100 % 100 % Branches: International General Insurance Company Ltd. - Labuan Branch Malaysia Reinsurance and insurance 100 % 100 % * International General Insurance Company (Europe) SE was acquired by the Group on 25 June 2021 (note 20). Restatement of Prior Period Comparative Figures On 12 April 2021, the SEC released a Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the “SEC Staff Statement”). The SEC Staff Statement highlighted potential accounting implications of certain terms that are common in warrants issued in connection with the initial public offerings of Special Purpose Acquisition Companies (“SPACs”). After considering the SEC Staff Statement and taking account of the circumstances of the transaction with Tiberius, the Group reevaluated its accounting treatment of the Public Warrants and Private Warrants (the “Warrants”) issued in connection with the initial public offering of Tiberius Acquisition Corp. (“Tiberius”) which were originally recorded as an equity instrument in the Group’s consolidated financial statements as a result of the Business Combination that occurred on 17 March 2020 (note 19). Accordingly, management has now accounted for the Warrants under IAS 32 ‘Financial Instruments’ rather than IFRS 2 ’Share-based Payment’ and concluded that the warrants agreement governing the Group’s Warrants includes contingent settlement provisions that provide potential changes and variability to the settlement amounts of the Warrants, dependent on the characteristics of the Warrants holder and the occurrence of some uncertain future events that are not within the control of the Group. In accordance with IAS 32, a contract to issue a variable number of shares fails to meet the definition of equity and must instead be classified as a derivative liability and measured at fair value with subsequent changes in fair value recorded in the interim condensed consolidated statement of income at the end of each reporting period. Based on this re-evaluation, management concluded that the Warrants represent a derivative liability that were deemed to have been issued upon consummation of the Business Combination. Due to this misstatement, management decided to restate the Group’s comparative figures for the six months ended 30 June 2020. As a result, the Warrants are now classified as a liability at fair value on the Group’s interim condensed consolidated statement of financial position as at 30 June 2020 and the change in the fair value of such liability in each period is recognised as a gain or loss in the Group’s interim condensed consolidated statements of income for the six months ended 30 June 2020. The correction of this misstatement resulted in a decrease in equity as at 30 June 2020 by USD 5,863 thousand and increase in liabilities with the same amount. For the six months ended 30 June 2020, a fair value gain of USD 3,347 thousand was also recognised in the interim condensed consolidated statement of income in the restated interim condensed consolidated financial statements with a consequent increase in the amount of the retained earnings in equity. Basic and diluted earnings per share for the prior period were also restated and the amount of the correction made was an increase of USD 0.07 per share to both basic and diluted earnings per share. There was no impact on cash from operating, financing or investing activities in the interim condensed consolidated statement of cash flows for the six months ended 30 June 2020. The following table reflects the impact of the restatement adjustments to the specific line items presented in the Group’s previously reported interim condensed consolidated financial statements for the six months ended 30 June 2020. The amounts as previously reported were derived from the Group’s original interim condensed consolidated financial statements. 30 June 2020 As previously reported Restatement adjustments As restated USD ’000 USD ’000 USD ’000 Interim condensed consolidated statements of financial position Equity: Warrants 12,213 (12,213 ) - Share premium 154,225 3,003 157,228 Retained earnings 193,306 3,347 196,653 Total equity 366,274 (5,863 ) 360,411 Liabilities: Derivative financial liability - 5,863 5,863 Total liabilities 800,902 5,863 806,765 Interim condensed consolidated statement of income Change in fair value of derivative financial liability - 3,347 3,347 Profit before tax 11,593 3,347 14,940 Profit for the period 11,160 3,347 14,507 Basic and dilutive earnings per share (USD) 0.26 0.07 0.33 Interim condensed consolidated statement of comprehensive income Total comprehensive income for the period 13,265 3,347 16,612 Changes in accounting policies The accounting policies used in the preparation of the interim condensed consolidated financial statements are consistent with those used in the preparation of the annual consolidated financial statements for the year ended 31 December 2020. There are no new standards or amendments effective in 2021 that have a material impact on the Group’s interim condensed consolidated financial statements.

Cash at Banks

Cash at Banks	6 Months Ended
	Jun. 30, 2021
Disclosure of Cash and Banks [Abstract]
CASH AT BANKS	(a) CASH AND CASH EQUIVALENTS 30 June 2021 31 December 2020 USD ’000 USD ’000 Cash and bank balances* 169,033 120,303 Deposits with original maturities of three months or less 11,101 13,136 180,134 133,439 * This item includes cash in the amount of USD 5,400 thousand placed in a trust account in favor of the National Association of Insurance Commissioners (NAIC) to secure policyholders’ obligations in relation to US surplus and excess lines business licensed effective 1 April 2020 (31 December 2020: USD 5,400 thousand). In addition, this item includes a deposit in the amount of USD 5,000 thousand (31 December 2020: USD 5,000 thousand) placed in favor of the Group as collateral against reinsurance arrangements. The interest earned on this deposit is not recognised as investment income and is transferred to the reinsurance company on a semi-annual basis. (b) TERM DEPOSITS 30 June 2021 31 December 2020 USD ’000 USD ’000 Deposits with original maturities over three months and less than one year 152,114 138,510 Deposits with original maturities over one year 33,702 33,702 185,816 172,212 The deposits are denominated in US Dollars and other US Dollars pegged currencies. All deposits earned interest in the range between 0.03%-4.5% (31 December 2020: 0.2%-4.5%) and are held for varying periods between one month to less than 5 years (31 December 2020: between one month to less than 5 years) depending on the immediate cash requirements of the Group.

Investments

Investments	6 Months Ended
	Jun. 30, 2021
Disclosure of investments accounted for using equity method [text block] [Abstract]
INVESTMENTS	4. INVESTMENTS 30 June 2021 Amortized Cost Fair value through other comprehensive income Fair value through profit or loss Total USD ’000 USD ’000 USD ’000 USD ’000 Unquoted bonds* 2,972 - - 2,972 Quoted bonds - 404,026 - 404,026 Quoted funds and alternative investments - - 11,174 11,174 Quoted equities** - 17,600 14,339 31,939 Unquoted equities*** - 6,783 - 6,783 Expected credit losses and impairment (397 ) - - (397 ) 2,575 428,409 25,513 456,497 31 December 2020 Amortized Cost Fair value through other comprehensive income Fair value through profit or loss Total USD ’000 USD ’000 USD ’000 USD ’000 Unquoted bonds* 3,103 - - 3,103 Quoted bonds - 390,918 - 390,918 Quoted funds and alternative investments - - 9,791 9,791 Quoted equities** - 14,935 12,989 27,924 Unquoted equities*** - 6,748 - 6,748 Expected credit losses and impairment (397 ) - - (397 ) 2,706 412,601 22,780 438,087 The movement on the expected credit losses and impairment provision for the bonds at amortized cost is as follows: 30 June 2021 31 December USD ’000 USD ’000 Opening balance 397 268 Addition of provision for investment in debt securities - 129 Ending balance 397 397 The addition of allowance for bonds at FVTOCI for the period ended 30 June 2021 of USD 32 thousand (note 13) does not change the carrying amount of these investments (which are measured at fair value but gives rise to an equal and opposite gain in OCI). * The Group has an investment in an unquoted bond denominated in JOD (USD pegged currency) issued by ’Specialized Investment Compound Co.,’ a local company based in Jordan, which had an original maturity date of 22 February 2016. However, this company is currently under liquidation, due to which 85% of the original bond holdings with a nominal value amounting to USD 1,236 thousand were not paid on that maturity date. These bonds are backed up by collateral in the form of real estate properties. However, the Group management has provided USD 397 thousand to cover any potential impairment in the value of the collateral held against said investment by discounting the expected future cash flows generated from the underlying bond collaterals which mainly represent rental income. ** In 2020, the Group has sold part of its holdings in a quoted equity at fair value through OCI to take advantage of the increase in the market value of the investee. The quoted equities were purchased in 2011 and held as a long-term investment. Upon disposal, the fair value of the sold shares was USD 3,859 thousand and the cumulative fair value change of USD 2,341 thousand remained in the fair value reserve. *** The Group has two unquoted equity investments under level 3 designated at fair value through OCI valued at USD 6,427 thousand (31 December 2020: USD 6,314 thousand) and USD 356 thousand (31 December 2020: USD 434 thousand). As at 30 June 2021 and 31 December 2020, the Group has measured the fair value of the unquoted investment valued at USD 6,427 thousand (31 December 2020: USD 6,314 thousand) by adopting a market valuation approach namely ‘multiples-based valuation’ whereby earnings-based multiples of comparable companies were considered for the valuation. As at 30 June 2021, the Group has measured the fair value of the unquoted investment valued at USD 434 thousand (31 December 2020: USD 434 thousand), by adopting a market valuation approach namely ‘multiples-based valuation’ whereby earnings-based multiples of comparable companies were considered for the valuation. For the year ended 31 December 2020, the Group has measured the fair value of the unquoted investment by considering an official sale offer received subsequent to year-end, which did not materialize in 2021. There are no active markets for these investments. The table below shows the sensitivity of the fair value of Level 3 financial assets as at 30 June 2021 and 30 June 2020: % Positive impact Negative impact Valuation variables USD ’000 USD ’000 30 June 2021 +/-10 676 (676 ) Market multiples applied to a range of financial performance measures**** 30 June 2020 +/-10 572 (572 ) Market multiples applied to a range of financial performance measures**** **** As at 30 June 2021, the fair value measurement of the unquoted equity investment valued at USD 6,427 thousand (30 June 2020: USD 6,504 thousand) was based on a combination of valuation multiples, with greater weight given to price to book value multiple. This has implied an equity value range of USD 5,778 thousand to USD 7,076 thousand (30 June 2020: USD 6,011 thousand to USD 6,997 thousand).

Investments in Associates

Investments in Associates	6 Months Ended
	Jun. 30, 2021
Descrption Of Accounting Policy For Investments In Associates [Abstract]
INVESTMENTS IN ASSOCIATES	5. INVESTMENTS IN ASSOCIATES The Group holds 32.7% equity ownership interest in companies registered in Lebanon as shown below, the investments in associated companies are accounted for using the equity method: Country of incorporation Ownership 30 June 2021 31 December Star Rock SAL Lebanon Lebanon 32.7 % 32.7 % Sina SAL Lebanon Lebanon 32.7 % 32.7 % Silver Rock SAL Lebanon Lebanon 32.7 % 32.7 % Golden Rock SAL Lebanon Lebanon 32.7 % 32.7 % Movement on investments in associates is as follows: 30 June 2021 31 December USD ’000 USD ’000 Opening balance 11,583 13,062 Share of associated companies’ financial results 35 (79 ) Investment properties’ fair value adjustment (1,091 ) (1,902 ) Foreign exchange gain arising from revaluation of associated companies 1,314 - Reversal of provision for contingent liabilities - 502 Share of profit (loss) from associates 258 (1,479 ) 11,841 11,583 The associates’ main business is investing in investment properties located in Beirut, Lebanon. The investment properties of the associates are stated at fair value to bring the associated companies’ accounting policies in line with that of the Group’s. The fair values of the investment properties have been determined by management and in doing so, management has considered valuation performed by third party specialist. The valuation model used was in accordance with that recommended by the International Valuation Standards Committee. The investment properties are valued using the sales comparison approach. Under the sales comparison approach, a property’s fair value is estimated based on comparable transactions. The sales comparison approach is based upon the principle of substitution under which a potential buyer will not pay more for the property than it will cost to buy a comparable substitute property. The unit of comparison applied by the Group is the price per square meter (sqm) which represents the significant unobservable input used in the valuation process. All the investment properties generated rental income during the current period and the prior years. The sensitivity of the Group’s interim condensed consolidated statement of income for the six months periods ended 30 June 2021 and 2020 to the change in the price used for the valuation of the investment properties owned by the associates was as follows: % Impact on interim condensed consolidated statement of income for the increase in price per square meter Impact on interim condensed consolidated statement of income for the decrease in price per square meter USD ’000 USD ’000 30 June 2021 +/- 20 3,796 (3,796 ) 30 June 2020 +/- 20 2,757 (2,757 )

Outstanding Claims

Outstanding Claims	6 Months Ended
	Jun. 30, 2021
Disclosure Of Claims And Benefits Outstanding Claims [Abstract]
OUTSTANDING CLAIMS	6. OUTSTANDING CLAIMS Movement in outstanding claims 30 June 2021 31 December 2020 Gross Reinsurers’ share Net Gross Reinsurers’ share Net USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 At the beginning of the period / year Reported claims 312,334 (160,373 ) 151,961 292,722 (163,191 ) 129,531 Claims incurred but not reported 179,921 (27,112 ) 152,809 120,331 (13,021 ) 107,310 492,255 (187,485 ) 304,770 413,053 (176,212 ) 236,841 Claims paid (49,917 ) 13,819 (36,098 ) (134,761 ) 51,018 (83,743 ) Provided during the period / year related to current accident year 124,862 (33,273 ) 91,589 225,950 (68,135 ) 157,815 Provided during the period / year related to previous accident years (22,099 ) 20,376 (1,723 ) (11,987 ) 5,844 (6,143 ) At the end of the period / year 545,101 (186,563 ) 358,538 492,255 (187,485 ) 304,770 At the end of the period / year Reported claims 325,578 (143,973 ) 181,605 312,334 (160,373 ) 151,961 Claims incurred but not reported 219,523 (42,590 ) 176,933 179,921 (27,112 ) 152,809 545,101 (186,563 ) 358,538 492,255 (187,485 ) 304,770

Investment Properties

Investment Properties	6 Months Ended
	Jun. 30, 2021
Disclosure of investment property [text block] [Abstract]
INVESTMENT PROPERTIES	7. INVESTMENT PROPERTIES The following table includes summarized information of the Group’s investment properties: 30 June 2021 Commercial building Lands* Total USD ’000 USD ’000 USD ’000 Opening balance 18,168 1,844 20,012 Additions 23 - 23 Sale of investment properties - (432 ) (432 ) Fair value adjustment (815 ) - (815 ) Ending balance 17,376 1,412 18,788 31 December 2020 Commercial building Lands* Total USD ’000 USD ’000 USD ’000 Opening balance 20,063 5,649 25,712 Additions 32 42 74 Sale of investment properties - (3,739 ) (3,739 ) Fair value adjustment (1,899 ) (108 ) (2,007 ) Foreign currency adjustment (28 ) - (28 ) Ending balance 18,168 1,844 20,012 * Lands amounting to USD 1,412 thousand as at 30 June 2021 (31 December 2020: USD 1,844 thousand) are registered in the name of a former Director. The Group has obtained a proxy and has full control over these investment properties (note 14). In 2021, the Group sold a number of plots with total carrying value of USD 432 thousand (30 June 2020: USD 1,277 thousand) and recognized a loss of USD 1 thousand (30 June 2020: loss of USD 41 thousand). The fair values of investment properties have been determined by management and in doing so has considered a valuation performed by third parties who are specialists in valuing these types of investment properties. The valuation model used was in accordance with that recommended by the International Valuation Standards Committee. The investment properties are valued using the sales comparison approach. Under the sales comparison approach, a property’s fair value is estimated based on comparable transactions. The sales comparison approach is based upon the principle of substitution under which a potential buyer will not pay more for the property than it will cost to buy a comparable substitute property. The management believes that this valuation technique falls under level 3 of the fair value hierarchy since investment properties market is not very active. The sensitivity of the Group’s interim condensed consolidated statement of income for the six months periods ended 30 June 2021 and 2020 to the change in the price used for the valuation of the investment properties was as follows: % Average price per square meter Impact on interim condensed consolidated statement of income for the increase in price per square meter Impact on interim condensed consolidated statement of income for the decrease in price per square meter USD USD ’000 USD ’000 Commercial building 30 June 2021 +/- 10 971 1,735 (1,735 ) 30 June 2020 +/- 10 1,094 1,957 (1,957 ) % Average price per square meter Impact on interim condensed consolidated statement of income for the increase in price per square meter Impact on interim condensed consolidated statement of income for the decrease in price per square meter USD USD ’000 USD ’000 Lands 30 June 2021 +/- 10 188 141 (141 ) 30 June 2020 +/- 10 195 419 (419 )

Property, Premises and Equipmen

Property, Premises and Equipment	6 Months Ended
	Jun. 30, 2021
Disclosure of property, plant and equipment [text block] [Abstract]
PROPERTY, PREMISES AND EQUIPMENT	8 (a). PROPERTY, PREMISES AND EQUIPMENT The additions to the property and equipment during the six-months period ended 30 June 2021 were USD 267 thousand (30 June 2020: USD 115 thousand). The depreciation expense for the six-months period ended 30 June 2021 was USD 634 thousand (30 June 2020: USD 632 thousand). Pursuant to the application of IFRS 16 -Lease, the Group has recognized a total amount of USD 3,101 thousand as a right-of-use assets for the leased offices (31 December 2020: USD 2,914 thousand). During the period ended 30 June 2021, interest expense amounted to USD 91 thousand (30 June 2020: USD 49 thousand) and depreciation expense of USD 565 thousand (30 June 2020: USD 278 thousand) was recognized for the leased assets.

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2021
Disclosure of intangible assets [text block] [Abstract]
INTANGIBLE ASSETS	8 (b). INTANGIBLE ASSETS The additions to the intangible assets during the six-months period ended 30 June 2021 were USD 1,420 thousand (30 June 2020: USD 6 thousand). The amortization expense for the six-months period ended 30 June 2021 was USD 672 thousand (30 June 2020: USD 213 thousand).

Derivative Financial Liability

Derivative Financial Liability	6 Months Ended
	Jun. 30, 2021
Derivative Financial Liability [Abstract]
DERIVATIVE FINANCIAL LIABILITY	9. DERIVATIVE FINANCIAL LIABILITY In connection with the Business Combination (note 19), the Group issued 17,250,000 warrants, including (i) 12,750,000 warrants issued to former stockholders of Tiberius (the “Public Warrants”) and (ii) 4,500,000 warrants that were issued in exchange for 4,000,000 Tiberius warrants transferred to Wasef Jabsheh and 500,000 Tiberius warrants transferred to Argo Re Ltd., a Bermuda exempted company (the “Private Warrants”). No Public or Private Warrants have been exercised or redeemed since originally issued and until the date of these interim condensed consolidated financial statements. Upon initial recognition, the fair value of the Warrants has been determined using a combination of a market approach and valuation technique performed by an independent third-party valuation specialist (for further details refer to note 19). Based on that, the estimated fair value of the Warrants was USD 9,210 thousand. As at 30 June 2021 and 31 December 2020, the Warrants were valued using the market quoted price on Nasdaq. The table below illustrates the movement on the Warrants during the period / year: 30 June 2021 31 December USD ’000 USD ’000 Fair value of Warrants at the beginning of the period / Initial recognition of Warrants at the close of the Business Combination - now reclassified from equity to a liability 13,628 9,210 Change in fair value for the period / year 3,795 4,418 Fair value of Warrants at the end of the period / year 17,423 13,628

Common Shares

Common Shares	6 Months Ended
	Jun. 30, 2021
Disclosure Of Common Shares Explanatory [Abstract]
COMMON SHARES	10. COMMON SHARES Under the Amended and Restated Bye-laws, the authorized share capital of the Group consists of 750,000,000 common shares, par value USD 0.01 per share, and 100,000,000 preference shares, par value USD 0.01 per share. As at 31 December 2019 as well as immediately prior to the closing of the Business Combination on 17 March 2020 (the “Closing”), the Company was authorized to issue 1,000 common shares, USD 0.01 par value per share and 1,000 preference shares, USD 0.01 par value per share, and there was one common share issued and outstanding and no preference shares issued and outstanding. As at 17 March 2020, subsequent to the Closing, and as at 31 December 2020, the authorized share capital was increased and there were 48,447,306 common shares issued and outstanding (including 3,012,500 common shares (“Earnout Shares”) subject to vesting but which are issued and outstanding for purposes of voting and receipt of dividends), and no preference shares issued and outstanding. All of the issued and outstanding common shares are fully paid. In connection with the finalization of the purchase price under the Business Combination Agreement, all escrow shares were released from escrow and 8,555 shares were cancelled. The following table sets out the number of common shares issued and outstanding as at 30 June 2021 and 31 December 2020: 30 June 2021 No. of shares Par value USD ’000 Common shares (par value of USD 0.01) 45,471,084 455 Earnout shares* (par value of USD 0.01) 3,012,500 30 Restricted shares awards (par value of USD 0.01) (note 11) 399,857 4 48,883,441 489 31 December 2020 No. of shares Par value USD ’000 Common shares (par value of USD 0.01) 45,426,251 455 Earnout shares* (par value of USD 0.01) 3,012,500 30 Restricted shares awards (par value of USD 0.01) (note 11) 134,500 1 48,573,251 486 * The Earnout Shares are subject to vesting at stock prices ranges from USD 11.50 to USD 15.25. The Earnout Shares are considered outstanding shares and have dividend and voting rights. However, the Earnout Shares are non-transferable by their holders until they vest and, if the Earnout Shares do not vest on or prior to 17 March 2028, they will be cancelled by the Company.

Share-Based Payments

Share-Based Payments	6 Months Ended
	Jun. 30, 2021
Disclosure of share-based payment arrangements [text block] [Abstract]
SHARE-BASED PAYMENTS	11. SHARE-BASED PAYMENTS On 3 June 2020, the Board of Directors approved the Group’s share-based employee compensation plan, the 2020 Omnibus Incentive Plan (“the Plan”). Under the Plan, the following awards may be granted: - Options to buy Common Shares (“Stock Options”), which may be either incentive stock options (“Incentive Stock Options” or “ISOs”) qualified under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or non-qualified stock options (“Non-Qualified Stock Options” or “NQSOs”), which do not satisfy the requirements of Incentive Stock Options; - Share appreciation rights (“SARs”) (including tandem, non-tandem and limited SARs); - Restricted shares awards (“Restricted Shares Awards”); - Performance awards denominated in Common Shares or cash (“Performance Awards”); - Other share-based awards (“Other Share-Based Awards”), including but not limited to restricted share units (“RSUs”); and - Other cash-based awards (“Other Cash-Based Awards”). On 30 September 2020, the Board of Directors approved the grant of 134,500 restricted shares (the “Restricted Shares Awards”) to certain participants (designated employees) with the following salient features: Grant date 7 October 2020 First vesting date (tranche 1) 2 January 2021 Second vesting date (tranche 2) 2 January 2022 Third vesting date (tranche 3) 2 January 2023 Total number of restricted shares awards 134,500 Number of restricted shares awards vesting each period 44,833 Grant date fair value (USD) 7.896 On 16 February 2021, the Board of Directors approved the grant of 180,000 restricted shares to certain participants (designated employees) with the following salient features: Grant date 16 February 2021 First vesting date (tranche 1) 2 January 2022 Second vesting date (tranche 2) 2 January 2023 Third vesting date (tranche 3) 2 January 2024 Total number of restricted shares awards 180,000 Number of restricted shares awards vesting each period 60,000 Grant date fair value (USD) 7.940 On 31 March 2021, the Board of Directors approved the grant of 132,190 restricted shares to Wasef Jabsheh (designated employee) with the following salient features: Grant date 31 March 2021 First vesting date (tranche 1) 2 January 2022 Second vesting date (tranche 2) 2 January 2023 Third vesting date (tranche 3) 2 January 2024 Total number of restricted shares awards 132,190 Number of restricted shares awards vesting each period 44,063 Grant date fair value (USD) 8.170 Grant date fair values represent the closing quoted prices of the Company’s share on Nasdaq on the dates when awards were officially communicated to the participants and shall be applicable for all the three vesting tranches. Participant’s continued service with the Company or any of its Subsidiaries on each applicable vesting date is the only vesting condition to be met. There is no other performance related condition attached to the vesting of shares. The movement on the number of restricted shares during the period / year is as follows: 30 June 31 December Balance at 1 January 134,500 - Restricted shares granted 312,190 134,500 Restricted shares vested (44,833 ) - Restricted shares forfeited (2,000 ) - Balance at end of the period / year 399,857 134,500 The Company has applied the graded vesting method in recognition of share-based payment expense. Accordingly, the Company has assessed the expected length of service period from date of shares grant until end of each vesting period respectively and considered this to determine proportionate earnout shares at 30 June 2021 and 31 December 2020 attributed to each vesting tranche. Number of earnout shares to be considered for accounting purposes at year end for each tranche are as follow: Grant Days from grant date Earn out shares from first Earn out shares from second Earn out shares from third Total 30 June 2021 30 September 2020 grant 267 1,019 17,324 9,594 27,937 16 February 2021 grant 92 14,582 6,304 4,022 24,908 31 March 2021 grant 135 25,234 11,807 7,707 44,748 Total 40,835 35,435 21,323 97,593 31 December 2020 30 September 2020 grant 88 43,814 8,511 4,714 57,039 Accordingly, total earnout shares of 97,593 at 30 June 2021 (31 December 2020: 57,039) are measured at the shares grant date fair value to arrive at expense recognized for the share based payment. For the period ended 30 June 2021, share-based payments expense of USD 779 thousand (30 June 2020: Nil

Cash Dividends

Cash Dividends	6 Months Ended
	Jun. 30, 2021
Disclosure of cash and cash equivalents [text block] [Abstract]
CASH DIVIDENDS	12. CASH DIVIDENDS Cash dividends declared and paid: The Board of Directors resolved to pay the following dividends for the period ended 30 June 2021: - On 25 March 2021: USD 8,288 thousand (Dividend per share: USD 0.17) There were no dividends paid or declared during the six months period ended 30 June 2020. There are no cash dividends declared but not paid as at 30 June 2021 and 31 December 2020.

Net Investment Income

Net Investment Income	6 Months Ended
	Jun. 30, 2021
Disclosure of investment entities [text block] [Abstract]
NET INVESTMENT INCOME	13. Net INVESTMENT InCOME For the six months ended 30 June 2021 2020 USD ’000 USD ’000 Interest income 7,742 5,412 Dividends from equities at FVTOCI 43 84 Dividends from equities at FVTPL 456 357 Realized gains and losses on investments Realized loss on sale of bonds at FVTOCI (321 ) (113 ) Realized gain on sale of equities and mutual funds at FVTPL 484 1,639 Unrealized gains and losses on investments Unrealized gain (loss) on revaluation of financial assets at FVTPL 2,128 (2,854 ) Gains and losses from investment properties Realized loss on sale of investment properties (1 ) (41 ) Unrealized loss on investment properties (815 ) (724 ) Rental income 89 84 Expected credit losses on investments Expected credit loss on financial assets at FVOCI (32 ) (65 ) Expected credit loss on financial assets at amortized cost - (1 ) Investments custodian fees and other investments expenses (443 ) (726 ) 9,330 3,052

Related party transactions

Related party transactions	6 Months Ended
	Jun. 30, 2021
Disclosure of related party [text block] [Abstract]
RELATED PARTY TRANSACTIONS	14. Related party transactions Related parties represent major shareholders, associates, directors and key management personnel of the Group and entities controlled, jointly controlled or significantly influenced by such parties. Pricing policies and terms of these transactions are approved by the Group’s management. ◾ Compensation of key management personnel of the Group for the period ended 30 June 2021, consisting of salaries and benefits was USD 2,280 thousand (30 June 2020: USD 2,249 thousand). Out of the total amount of key management personnel compensation, an amount of USD 538 thousand (30 June 2020: USD 887 thousand) represents long-term benefits. Out of these long-term benefits, an amount of USD 538 thousand of long-term benefits represents earn out value of share-based expenses as of 30 June 2021 (30 June 2020: USD Nil Post completion of the Business Combination, the Group has reviewed its list of ‘key management personnel’ in accordance with IAS 24 (Related Party Disclosures) requirements and accordingly considered the persons who were named as executive officers of the company in its SEC filings as ‘Key management personnel’. Those officers have the authority and responsibility for planning, directing, and controlling the activities of the Group. In addition, they represent the Group’s executive committee which acts in the capacity of chief operating decision maker (note 18). ◾ The Group has paid aircraft management fees and chartering revenues commission in the amount of USD 131 thousand (30 June 2020: USD 52 thousand) to Arab Wings Co. where a shareholder has a controlling interest. As at 30 June 2021, there was an amount of USD 181 thousand receivable from Arab Wings Co. (31 December 2020: Receivable of USD 37 thousand). ◾ No balances from key management personnel of the Group were due as at 30 June 2021 and 31 December 2020. ◾ Included within the investment properties (note 7) are lands with a total amount of USD 1,412 thousand as at 30 June 2021 (31 December 2020: USD 1,844 thousand) registered in the name of a former Director of the Group. The Group has obtained a proxy and has full control over these investment properties. ◾ In connection with the Business Combination (note 19) the Group issued 4,000,000 warrants in exchange for 4,000,000 Tiberius warrants transferred to Wasef Jabsheh (the Chief Executive Officer and Chairman of the Board of Directors) (note 9). As at 30 June 2021, none of the Warrants has been exercised or redeemed since originally issued.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2021
Disclosure of earnings per share [text block] [Abstract]
EARNINGS PER SHARE	15. EaRNINGS PER SHARE Basic earnings per share represents the profits attributable to the ordinary shareholders divided by the weighted average number of common shares outstanding during the periods. Diluted earnings per share represents the profits attributable to the ordinary shareholders divided by the weighted average number of ordinary shares outstanding during the period plus the weighted average number of ordinary shares that would be issued on conversion of all the dilutive potential ordinary shares into ordinary shares. As at 30 June 2021, part of the restricted shares awards were unvested. However, since these shares contain a nonforfeitable rights to dividends, whether paid or unpaid, they are considered as participating securities and hence included in the computation of both basic and diluted earnings per share. At the closing of the Business Combination, the Group issued 17,250,000 warrants, including (i) 12,750,000 warrants issued to former stockholders of Tiberius and (ii) 4,500,000 warrants that were issued in exchange for 4,000,000 Tiberius warrants transferred to Wasef Jabsheh and 500,000 Tiberius warrants transferred to Argo Re Ltd., a Bermuda exempted company (note 19). The Warrants were not included in the calculation of the diluted earnings per share, as the average market price of ordinary shares during the period has not exceeded the exercise price of the Warrants and therefore their effect would be antidilutive. The following table shows the calculation of the basic and diluted earnings per share for the six months ended 30 June 2021 and 2020. For the six months ended 2021 2020 (Restated) Profit for the period (USD ’000) 18,426 14,507 Less: profit attributable to the Earnout Shares (USD ’000) (1,135 ) (902 ) Less: profit attributable to the restricted shares awards (note 11) (USD ’000) (168 ) - Net profit available to common shareholders (USD ’000) 18,677 13,605 Weighted average number of shares – basic and diluted 45,470,835 40,630,159 Basic and diluted earnings per share (USD) 0.38 0.33

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Disclosure of commitments [text block] [Abstract]
COMMITMENTS AND CONTINGENCIES	16. COMMITMENTS AND CONTINGENCIES As at 30 June 2021, the Group is contingently liable for the following: ◾ Letters of Credit amounting to USD 9,193 thousand to the order of reinsurance companies for collateralizing insurance contract liabilities in accordance with the reinsurance arrangements (31 December 2020: USD 7,994 thousand). ◾ Letter of Guarantee amounting to USD 334 thousand to the order of Friends Provident Life Assurance Limited for collateralizing a rent payment obligation in one of the Group entity’s office premises (31 December 2020: USD 321 thousand). Litigation The Group was engaged in an arbitration proceeding at 31 December 2020 with certain reinsurers represented by an underwriting agent (“agent”) with respect to certain matters related to the Group’s outward reinsurance programme for the years 2012 to 2017. The Group commenced the arbitration proceeding with the agent for these reinsurers after they failed to make payment of approximately USD 5.7 million which the Group believes is due from them (based on figures as at 30 June 2019). As at 31 December 2020, the Group was seeking to recover approximately USD 15.3 million from the reinsurers, plus interest and legal costs. In response, the agent alleged that certain matters were not adequately disclosed and was seeking to void the policies. The Group believes that the allegations were without merit and committed to vigorously defend itself in this matter. Accordingly, no provision for any liability was recorded in the prior year consolidated financial statements as at 31 December 2020. The arbitration hearing was scheduled for April 2021. Before the start of the final hearing in April 2021, the matters under arbitration were resolved (and the arbitration discontinued) between the Group and reinsurers. The outward reinsurance policies remain in full force and effect. The resolution has no material impact on the Group’s business, results of operations or financial condition.

Fair value

Fair value	6 Months Ended
	Jun. 30, 2021
Disclosure of fair value measurement [text block] [Abstract]
FAIR VALUE	17. Fair value The Group uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation techniques: Level 1 Level 2 Level 3 For assets and liabilities that are recognized in the financial statements on a recurring basis, the Group determines whether transfers have occurred between Levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period. 30 June 2021 Level 1 Level 2 Level 3 Total USD ’000 USD ’000 USD ’000 USD ’000 Assets measured at fair value: FVTPL 25,513 - - 25,513 Quoted equities at FVOCI 17,600 - - 17,600 Quoted bonds at FVOCI 404,026 - - 404,026 Unquoted equities at FVOCI* - - 6,783 6,783 Investment properties - - 18,788 18,788 447,139 - 25,571 472,710 Liabilities measured at fair value: Derivative financial liability 17,423 - - 17,423 31 December 2020 Level 1 Level 2 Level 3 Total USD ’000 USD ’000 USD ’000 USD ’000 Assets measured at fair value: FVTPL 22,780 - - 22,780 Quoted equities at FVOCI 14,935 - - 14,935 Quoted bonds at FVOCI 390,918 - - 390,918 Unquoted equities at FVOCI* - - 6,748 6,748 Investment properties - - 20,012 20,012 428,633 - 26,760 455,393 Liabilities measured at fair value: Derivative financial liability 13,628 - - 13,628 * Reconciliation of fair value of the unquoted equities under level 3 fair value hierarchy is as follows: 30 June 31 December USD ’000 USD ’000 Balance at the beginning of the period / year 6,748 5,794 Purchases - 1,503 Total losses recognized in OCI 35 (549 ) Balance at the end of the period / year 6,783 6,748

Segment Reporting

Segment Reporting	6 Months Ended
	Jun. 30, 2021
Description of accounting policy for segment reporting [text block] [Abstract]
SEGMENT REPORTING	18. Segment Reporting The Group’s chief operating decision maker (“CODM”) is the Executive Committee, which periodically reviews financial information at the business line level. Thus, each of the business lines in which the Group operates are considered operating segments. The Group has aggregated operating segments into the following reporting segments for the purposes of its interim condensed consolidated financial statements: 1. Specialty Long tail (comprising business lines with underwriting risks assumed in form of liability insurance and of a long-term nature with respect to related claims). 2. Specialty Short tail (comprising business lines with underwriting risks assumed in the form of property and specialty line insurance and of a short-term nature with respect to related claims). 3. Reinsurance which covers the inward reinsurance treaty and is a single operating segment. The Group is of the view that the quantitative and qualitative aspects of the aggregated operating segments are similar in nature for all periods presented. In evaluating the appropriateness of aggregating operating segments, the key indicators considered included but were not limited to: (i) nature of products, (ii) similarities of customer base, products, underwriting processes and outward reinsurance processes, (iii) regulatory environments and (iv) distribution methods. Segment performance is evaluated based on net underwriting results and is measured consistently with the overall net underwriting results in the interim condensed consolidated financial statements. The Group also has general and administrative expenses, net investment income, gain/loss on foreign exchange, other expenses/revenues, change in fair value of derivative financial liability and tax expense. These financial items are presented under “Corporate and Other” in the tables below as the Group does not allocate them to individual reporting segments. a) Segment disclosure for the Group’s consolidated operations is as follows: For the period ended 30 June 2021 Specialty Long tail Specialty Short tail Reinsurance Sub Total Corporate and Other Total USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 Underwriting revenues Gross written premiums 101,286 150,930 14,556 266,772 - 266,772 Reinsurer’s share of insurance premiums (26,847 ) (53,231 ) - (80,078 ) - (80,078 ) Net written premiums 74,439 97,699 14,556 186,694 - 186,694 Net change in unearned premiums 8,325 (23,932 ) (3,270 ) (18,877 ) - (18,877 ) Net premiums earned 82,764 73,767 11,286 167,817 - 167,817 Underwriting deductions Net policy acquisition expenses (13,994 ) (13,603 ) (1,792 ) (29,389 ) - (29,389 ) Net claims and claim adjustment expenses (46,176 ) (36,741 ) (6,949 ) (89,866 ) - (89,866 ) Net underwriting results 22,594 23,423 2,545 48,562 - 48,562 General and administrative expenses - - - - (29,284 ) (29,284 ) Net investment income - - - - 9,330 9,330 Share of profit from associates - - - - 258 258 Impairment loss on insurance receivables - - - - (1,121 ) (1,121 ) Other revenues - - - - 1,021 1,021 Other expenses - - - - (1,438 ) (1,438 ) Change in fair value of derivative financial liability - - - - (3,795 ) (3,795 ) Loss on foreign exchange - - - - (3,175 ) (3,175 ) Profit (loss) before tax 22,594 23,423 2,545 48,562 (28,204 ) 20,358 Income tax - - - - (1,932 ) (1,932 ) Profit (loss) for the period 22,594 23,423 2,545 48,562 (30,136 ) 18,426 For the period ended 30 June 2020 Specialty Long tail Specialty Short tail Reinsurance Sub Total Corporate and Other Total USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 Underwriting revenues Gross written premiums 82,986 142,080 11,435 236,501 - 236,501 Reinsurer’s share of insurance premiums (12,455 ) (53,424 ) - (65,879 ) - (65,879 ) Net written premiums 70,531 88,656 11,435 170,622 - 170,622 Net change in unearned premiums (6,133 ) (25,156 ) (3,083 ) (34,372 ) - (34,372 ) Net premiums earned 64,398 63,500 8,352 136,250 - 136,250 Underwriting deductions Net policy acquisition expenses (12,830 ) (11,671 ) (1,369 ) (25,870 ) - (25,870 ) Net claims and claim adjustment expenses (32,105 ) (30,508 ) (1,674 ) (64,287 ) - (64,287 ) Net underwriting results 19,463 21,321 5,309 46,093 - 46,093 General and administrative expenses - - - - (22,423 ) (22,423 ) Net investment income - - - - 3,052 3,052 Share of loss from associates - - - - (439 ) (439 ) Impairment loss on insurance receivables - - - - (2,178 ) (2,178 ) Other revenues - - - - 117 117 Other expenses - - - - (605 ) (605 ) Change in fair value of derivative financial liability - - - - 3,347 3,347 Listing related cost - - - - (3,366 ) (3,366 ) Loss on foreign exchange - - - - (8,658 ) (8,658 ) Profit (loss) before tax 19,463 21,321 5,309 46,093 (31,153 ) 11,593 Income tax - - - - (433 ) (433 ) Profit (loss) for the period (restated) 19,463 21,321 5,309 46,093 (31,586 ) 14,507 b) Non – current operating assets information by geography as at 30 June 2021 and 31 December 2020 are as follows: 30 June 31 December USD ’000 USD ’000 Middle East 33,567 34,631 North Africa 357 72 UK 3,199 3,112 Asia 51 75 37,174 37,890 Non-current assets for this purpose consist of property, plant and equipment, right-of-use assets, investment properties and intangible assets.

Business Combination

Business Combination	6 Months Ended
	Jun. 30, 2021
Disclosure of business combinations [text block] [Abstract]
BUSINESS COMBINATION	19. Business COMBination On 17 March 2020, the definitive business agreement between International General Insurance Holdings Limited - Dubai (“IGI”) and Tiberius Acquisition Corp. (NASDAQ: TIBR) (“Tiberius”), a publicly traded special purpose acquisition company, and certain related parties, was effective (the “Business Combination”). As a result of the completion of the Business Combination, the Company became a new public company owned by the former stockholders of Tiberius and the former shareholders of IGI. Consequently, IGI and Tiberius became the Company’s subsidiaries. Furthermore, in accordance with the Business Combination, USD 80,000 thousand of the transaction consideration was paid in cash to IGI former shareholders and accounted for as an adjustment against share premium in the consolidated statement of changes in equity. At the closing of the Business Combination, the Company: 1) Issued (1) 29,759,999 common shares to former shareholders of IGI in exchange for their IGI shares and (2) 18,687,307 common shares to former stockholders of Tiberius, including (I) 9,339,924 common shares issued in exchange for public shares of Tiberius common stock that remained outstanding and not redeemed immediately prior to the closing of the Business Combination, (ii) 4,132,500 common shares issued in exchange for Tiberius founder shares, including 3,012,500 common shares (“Earnout Shares”) subject to vesting at prices ranging from USD 11.50 to USD 15.25 per share, (iii) 2,900,000 common shares issued in exchange for shares of Tiberius common stock that were issued to certain investors in a private placement pursuant to forward purchase agreements, and (iv) 2,314,883 common shares issued in exchange for shares of Tiberius common stock that were issued to certain investors in a private placement. In connection with the finalization of the purchase price under the Business Combination Agreement, all escrow shares issued to former shareholders of IGI were released from escrow and 8,555 shares were cancelled. Following the cancellation, the Group has 48,438,751 shares outstanding (including the 3,012,500 unvested shares). Simultaneously with the execution of the Business Combination, out of total Earnout Shares issued to Tiberius founder shareholders, 1,170,348 shares were transferred to certain former shareholders of IGI. The following table sets out the number of common shares issued in connection with the Business Combination: No. of shares Par value of 0.01 USD USD ’000 Common shares issued to former shareholders of IGI 29,751,444 298 Common shares issued to former stockholders of Tiberius * 15,674,807 157 Unvested shares transferred to certain former shareholders of IGI 1,170,348 12 Unvested Tiberius Founder shares 1,842,152 18 48,438,751 485 * This item includes 1,120,000 shares that were subject to a one year lock-up restriction post the closing date of the Business Combination. 2) In addition, on 17 March 2020 the Company issued 17,250,000 warrants, including (i) 12,750,000 warrants issued to former stockholders of Tiberius and (ii) 4,500,000 warrants that were issued in exchange for 4,000,000 Tiberius warrants transferred to Wasef Jabsheh and 500,000 Tiberius warrants transferred to Argo Re Ltd., a Bermuda exempted company (note 9). 3) Eliminated IGI issued share capital in the amount of USD 143,376 thousand that ceased to exist upon consummation of the Business Combination. 4) Eliminated IGI treasury shares in the amount of USD 20,103 thousand. 5) Eliminated IGI additional paid in capital in the amount of USD 2,773 thousand. 6) Adjusted the share premium as a result of the issuance of the common shares and warrants. Accounting for the Business Combination The transaction was accounted for as a continuation of International General Insurance Holdings Limited - Dubai (“IGI”). Under this method of accounting, while the Company is the legal acquirer of both IGI and Tiberius, IGI has been identified as the accounting acquirer of Tiberius for accounting purposes. This determination was primarily based on IGI comprising the ongoing operations of the combined company, IGI senior management comprising the senior management of the combined company, and the former owners and management of IGI having control of the Board of Directors following the consummation of the transaction by virtue of being able to appoint a majority of the directors of the combined company. As Tiberius does not meet the definition of a business as defined in IFRS 3 - Business Combinations (“IFRS 3”), the purchase of the shares of the former owners of Tiberius is not within the scope of IFRS 3 and is accounted for as a share-based payment transaction in accordance with IFRS 2- Share-based payments (“IFRS 2”). Hence, the transaction was accounted for as the continuance of IGI with recognition of the identifiable assets acquired and the liabilities assumed of Tiberius at fair value. Operations prior to the transaction are those of IGI from an accounting point of view. Fair value measurement of the equity instruments issued in connection with the Business Combination In connection with the business combination, equity instruments that were issued as a share-based consideration to Tiberius were as follows: (a) Quoted common shares (b) Founder shares subject to a one year lock-up restriction (c) Earnout shares subject to vesting at differential price range Under IFRS 2, fair values of above-mentioned equity instruments issued to Tiberius was compared to fair value of Tiberius identifiable net assets acquired (representing net cash received by IGI and its former shareholders net of the liabilities assumed by IGI in the form of the Public Warrants which represent financial instruments issued to former stockholders of Tiberius) in order to determine gain or loss on acquisition on 17 March 2020 (the valuation date). In order to assess the appropriateness of using the closing quoted market price of Tiberius common stock on Nasdaq as a representative of the fair value of the common shares on the valuation date, management has performed liquidity assessment of Tiberius stock prior to the Business Combination from 11 March 2020 (being the last date of redemption rights available to Tiberius shareholders) until the valuation date. Management does not consider the quoted Tiberius price to be an appropriate representation of fair value based on the illiquidity observed in the quoted price over the period. Instead, management has appointed an independent third-party valuation specialist to perform a valuation using a market approach to estimate the fair value of equity instruments issued to Tiberius’s stockholders. Accordingly, as an alternative valuation technique, IGI Common Shares (“Common Shares”) were valued using a market multiples approach, namely ‘Price- To- Book ratio’ multiples benchmarked against ‘Return on Equity’ and consequentially corroborated using ‘Price -To- Earnings’ multiples of each comparable company. For the shares that are subject to one-year transfer restriction, fair value is determined after applying a lock-in discount to the fair value determined for the common shares. For purposes of determining the fair value of the Earnout Shares, a ‘Monte Carlo’ simulation approach was adopted to address the uncertainty of the time at which the shares will vest. In addition, this approach considers the share price as at the closing date, the threshold price, expected volatility (estimated using historical share price movements of comparable companies), expected dividend yield, the risk-free rate, and the earnout period. Based on the above, the following table summarizes the fair value of the equity instruments issued to Tiberius stockholders at the close of the Business Combination based on a market approach valuation: Equity Instruments No. of shares/warrants Fair value per share/warrant Fair value USD USD ’000 Common shares 14,554,807 6.85 99,715 Vested Founder shares subject to a one year lock-up restriction post Business Combination closing date 1,120,000 6.39 7,156 Unvested Tiberius Founder shares 1,842,152 3.48 6,407 Total Value of Consideration 113,278 Under IFRS 2, the transaction was measured at the fair value of the common shares deemed to have been issued by IGI for the ownership interest in the Company to be the same as if the transaction had taken the legal form of IGI acquiring 100% of Tiberius. The difference between the fair value equity instruments (common shares) “Value of Consideration” issued by IGI to Tiberius and the fair value of the later identifiable net assets acquired (representing net cash received by IGI and its former shareholders net liabilities assumed by IGI in the form of the Public Warrants which represent financial instruments issued to former stockholders of Tiberius) represents a bargain purchase. However, since the transaction is accounted for under IFRS 2 and the outcome of fair value measurement represents a ‘bargain’ and not an ‘expense’, there is no listing expense to be recognized for the services received by IGI in connection with the transaction. Using the fair valuation of the Common Shares (discussed above) as an input, the Public Warrants were valued as ‘American-style’ call options using a binomial tree approach on the valuation date. The details of Tiberius net assets acquired are shown below: Description USD ’000 Cash proceeds received 120,821 Less: liabilities assumed in the form of the Public Warrants (12,750,000 Public Warrants at fair value of USD 0.53 per warrant) (6,807 ) Net assets acquired 114,014 The following table illustrates the difference between the total Value of Consideration and net assets acquired at the closing date of the Business Combination. Description USD ’000 Value of Consideration 113,278 Less: net assets acquired (114,014 ) Bargain (736 ) Listing Related Expenses During the period ended 30 June 2020, the Group incurred listing expenses in the amount of USD 3,366 thousand which mainly consist of professional fees (legal, accounting, etc.) and other miscellaneous costs that are directly related to the listing transaction.

Acquisition of a Subsidiary

Acquisition of a Subsidiary	6 Months Ended
	Jun. 30, 2021
Description of accounting policy for subsidiaries [text block] [Abstract]
ACQUISITION OF A SUBSIDIARY	20. ACQUISITION OF A SUBSIDIARY Following the United Kingdom’s (“UK”) decision to withdraw from the European Union (“EU”) (“Brexit”), the U.K. began a process of “onshoring” EU legislation whereby the UK replicated EU law in UK legislation and regulation and then amended it so that it would be operationally effective following the end of the Brexit transition period on December 31, 2020. As an automatic consequence of the UK’s departure from the EU’s single market, passporting rights to and from the UK ended at the end of the transition period. Passporting is the exercise of the right available to a firm authorised in one European Economic Area (“EEA”) member state to carry on certain activities covered by an EU single market directive in another EEA member state, on the basis of its home state authorisation. For firms based in the UK, this means the loss of access to EU markets. As of the end of the transition period, the Group’s subsidiary in UK has lost its passporting rights in the EU, such that it can no longer write insurance business in EEA countries under the “freedom of services” regime or write insurance business through a place of business in an EEA member state under the “freedom of establishment” regime using the rights contained in the European Council’s Solvency II Directive. As a result, and in order for the Group to continue write insurance business in the EU, the Group acquired 100% of the voting shares of R&Q Epsilon Insurance Company SE (“R&Q Epsilon”), a non-listed company based in Malta engaged in the business of insurance in certain classes of general insurance business. Simultaneously, with the execution of the acquisition agreement, the new subsidiary was renamed International General Insurance Company (Europe) SE (“IGIE”). The acquisition agreement of R&Q Epsilon Insurance Company SE was fully executed on 25 June 2021 (the “Acquisition Date”) for a purchase consideration of USD 6,200 thousand. The Group accounted for the acquisition of R&Q Epsilon under IFRS 3 “Business Combinations”. As at the Acquisition Date, the book value of the net assets and liabilities of R&Q Epsilon was USD 6,200 thousand consisting of cash at banks of USD 6,054 and the remaining USD 146 thousand represents deferred tax assets and insurance receivables, net of other payable balances. As at 30 June 2021 (the end of the first reporting period), the Group has provisionally accounted for the acquisition of R&Q Epsilon and accordingly determined that the fair value of the net assets and liabilities was approximately equivalent to the book value. Nonetheless, in accordance with the one-year measurement period permitted under IFRS 3, the Group will reassess the provisional carrying amount of net identified asset and liabilities of R&Q Epsilon and will accordingly reflect any new information obtained about facts and circumstances that were in existence at the Acquisition Date. Subsequently, on 13 July 2021, the Malta Financial Services Authority (“MFSA”) authorised IGIE to write insurance and reinsurance business.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Disclosure of events after reporting period [text block] [Abstract]
SUBSEQUENT EVENTS	21. subsequent events There have been no material events between 30 June 2021 and the date of this report which are required to be disclosed.

Basis of Preparation (Tables)

Basis of Preparation (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of basis of preparation of financial statements [text block] [Abstract]
Schedule of subsidiaries	Country of incorporation Activity Ownership 30 June 2021 31 December International General Insurance Holdings Limited United Arab Emirates Reinsurance and insurance 100 % 100 % Tiberius Acquisition Corporation United States of America Special purpose acquisition company 100 % 100 % The following entities are wholly owned by the subsidiary International General Insurance Holdings Limited: I.G.I Underwriting /Jordan “Exempted” Jordan Underwriting agency 100 % 100 % North Star Underwriting Limited United Kingdom Underwriting agency 100 % 100 % International General Insurance Co. Ltd. Bermuda Reinsurance and insurance 100 % 100 % The following entities are wholly owned subsidiaries and branches by International General Insurance Co. Ltd. Bermuda: Subsidiaries: International General Insurance Company (UK) Limited United Kingdom Reinsurance and insurance 100 % 100 % International General Insurance Company (Dubai) Ltd. United Arab Emirates Insurance intermediation and insurance management 100 % 100 % International General Insurance Company (Europe) SE* Malta Reinsurance and insurance 100 % - Specialty Malls Investment Company Jordan Real estate properties development and lease 100 % 100 % IGI Services Ltd Cayman Islands Owning and chartering aircraft 100 % 100 % Branches: International General Insurance Company Ltd. - Labuan Branch Malaysia Reinsurance and insurance 100 % 100 %
Schedule of interim condensed consolidated statements of financial position	30 June 2020 As previously reported Restatement adjustments As restated USD ’000 USD ’000 USD ’000 Interim condensed consolidated statements of financial position Equity: Warrants 12,213 (12,213 ) - Share premium 154,225 3,003 157,228 Retained earnings 193,306 3,347 196,653 Total equity 366,274 (5,863 ) 360,411 Liabilities: Derivative financial liability - 5,863 5,863 Total liabilities 800,902 5,863 806,765 Interim condensed consolidated statement of income Change in fair value of derivative financial liability - 3,347 3,347 Profit before tax 11,593 3,347 14,940 Profit for the period 11,160 3,347 14,507 Basic and dilutive earnings per share (USD) 0.26 0.07 0.33 Interim condensed consolidated statement of comprehensive income Total comprehensive income for the period 13,265 3,347 16,612

Cash at Banks (Tables)

Cash at Banks (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of cash and bank balances at central banks [text block] [Abstract]
Schedule of cash and cash equivalents	30 June 2021 31 December 2020 USD ’000 USD ’000 Cash and bank balances* 169,033 120,303 Deposits with original maturities of three months or less 11,101 13,136 180,134 133,439
Schedule of term deposits	30 June 2021 31 December 2020 USD ’000 USD ’000 Deposits with original maturities over three months and less than one year 152,114 138,510 Deposits with original maturities over one year 33,702 33,702 185,816 172,212

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of investments accounted for using equity method [text block] [Abstract]
Schedule of group financial investments	30 June 2021 Amortized Cost Fair value through other comprehensive income Fair value through profit or loss Total USD ’000 USD ’000 USD ’000 USD ’000 Unquoted bonds* 2,972 - - 2,972 Quoted bonds - 404,026 - 404,026 Quoted funds and alternative investments - - 11,174 11,174 Quoted equities** - 17,600 14,339 31,939 Unquoted equities*** - 6,783 - 6,783 Expected credit losses and impairment (397 ) - - (397 ) 2,575 428,409 25,513 456,497 31 December 2020 Amortized Cost Fair value through other comprehensive income Fair value through profit or loss Total USD ’000 USD ’000 USD ’000 USD ’000 Unquoted bonds* 3,103 - - 3,103 Quoted bonds - 390,918 - 390,918 Quoted funds and alternative investments - - 9,791 9,791 Quoted equities** - 14,935 12,989 27,924 Unquoted equities*** - 6,748 - 6,748 Expected credit losses and impairment (397 ) - - (397 ) 2,706 412,601 22,780 438,087
Schedule of expected credit losses and impairment provision for the bonds	30 June 2021 31 December USD ’000 USD ’000 Opening balance 397 268 Addition of provision for investment in debt securities - 129 Ending balance 397 397
Schedule of fair value of level 3 financial assets	% Positive impact Negative impact Valuation variables USD ’000 USD ’000 30 June 2021 +/-10 676 (676 ) Market multiples applied to a range of financial performance measures**** 30 June 2020 +/-10 572 (572 ) Market multiples applied to a range of financial performance measures**** **** As at 30 June 2021, the fair value measurement of the unquoted equity investment valued at USD 6,427 thousand (30 June 2020: USD 6,504 thousand) was based on a combination of valuation multiples, with greater weight given to price to book value multiple. This has implied an equity value range of USD 5,778 thousand to USD 7,076 thousand (30 June 2020: USD 6,011 thousand to USD 6,997 thousand).

Investments in Associates (Tabl

Investments in Associates (Tables)	6 Months Ended
	Jun. 30, 2021
Descrption Of Accounting Policy For Investments In Associates [Abstract]
Schedule of investments in associated companies equity method	Country of incorporation Ownership 30 June 2021 31 December Star Rock SAL Lebanon Lebanon 32.7 % 32.7 % Sina SAL Lebanon Lebanon 32.7 % 32.7 % Silver Rock SAL Lebanon Lebanon 32.7 % 32.7 % Golden Rock SAL Lebanon Lebanon 32.7 % 32.7 %
Schedule of movement on investments in associates	30 June 2021 31 December USD ’000 USD ’000 Opening balance 11,583 13,062 Share of associated companies’ financial results 35 (79 ) Investment properties’ fair value adjustment (1,091 ) (1,902 ) Foreign exchange gain arising from revaluation of associated companies 1,314 - Reversal of provision for contingent liabilities - 502 Share of profit (loss) from associates 258 (1,479 ) 11,841 11,583
Schedule of financial statements to the change in the price used for the valuation of the investment properties	% Impact on interim condensed consolidated statement of income for the increase in price per square meter Impact on interim condensed consolidated statement of income for the decrease in price per square meter USD ’000 USD ’000 30 June 2021 +/- 20 3,796 (3,796 ) 30 June 2020 +/- 20 2,757 (2,757 )

Outstanding Claims (Tables)

Outstanding Claims (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure Of Claims And Benefits Outstanding Claims [Abstract]
Schedule of movement in outstanding claims	30 June 2021 31 December 2020 Gross Reinsurers’ share Net Gross Reinsurers’ share Net USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 At the beginning of the period / year Reported claims 312,334 (160,373 ) 151,961 292,722 (163,191 ) 129,531 Claims incurred but not reported 179,921 (27,112 ) 152,809 120,331 (13,021 ) 107,310 492,255 (187,485 ) 304,770 413,053 (176,212 ) 236,841 Claims paid (49,917 ) 13,819 (36,098 ) (134,761 ) 51,018 (83,743 ) Provided during the period / year related to current accident year 124,862 (33,273 ) 91,589 225,950 (68,135 ) 157,815 Provided during the period / year related to previous accident years (22,099 ) 20,376 (1,723 ) (11,987 ) 5,844 (6,143 ) At the end of the period / year 545,101 (186,563 ) 358,538 492,255 (187,485 ) 304,770 At the end of the period / year Reported claims 325,578 (143,973 ) 181,605 312,334 (160,373 ) 151,961 Claims incurred but not reported 219,523 (42,590 ) 176,933 179,921 (27,112 ) 152,809 545,101 (186,563 ) 358,538 492,255 (187,485 ) 304,770

Investment Properties (Tables)

Investment Properties (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of investment property [text block] [Abstract]
Schedule of investment properties	30 June 2021 Commercial building Lands* Total USD ’000 USD ’000 USD ’000 Opening balance 18,168 1,844 20,012 Additions 23 - 23 Sale of investment properties - (432 ) (432 ) Fair value adjustment (815 ) - (815 ) Ending balance 17,376 1,412 18,788 31 December 2020 Commercial building Lands* Total USD ’000 USD ’000 USD ’000 Opening balance 20,063 5,649 25,712 Additions 32 42 74 Sale of investment properties - (3,739 ) (3,739 ) Fair value adjustment (1,899 ) (108 ) (2,007 ) Foreign currency adjustment (28 ) - (28 ) Ending balance 18,168 1,844 20,012
Schedule of change in the price used for the valuation of the investment properties	% Average price per square meter Impact on interim condensed consolidated statement of income for the increase in price per square meter Impact on interim condensed consolidated statement of income for the decrease in price per square meter USD USD ’000 USD ’000 Commercial building 30 June 2021 +/- 10 971 1,735 (1,735 ) 30 June 2020 +/- 10 1,094 1,957 (1,957 ) % Average price per square meter Impact on interim condensed consolidated statement of income for the increase in price per square meter Impact on interim condensed consolidated statement of income for the decrease in price per square meter USD USD ’000 USD ’000 Lands 30 June 2021 +/- 10 188 141 (141 ) 30 June 2020 +/- 10 195 419 (419 )

Derivative Financial Liability

Derivative Financial Liability (Tables)	6 Months Ended
	Jun. 30, 2021
Derivative Financial Liability [Abstract]
Schedule of private warrants	30 June 2021 31 December USD ’000 USD ’000 Fair value of Warrants at the beginning of the period / Initial recognition of Warrants at the close of the Business Combination - now reclassified from equity to a liability 13,628 9,210 Change in fair value for the period / year 3,795 4,418 Fair value of Warrants at the end of the period / year 17,423 13,628

Common Shares (Tables)

Common Shares (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure Of Common Shares Explanatory [Abstract]
Schedule of number of common shares issued and outstanding	30 June 2021 No. of shares Par value USD ’000 Common shares (par value of USD 0.01) 45,471,084 455 Earnout shares* (par value of USD 0.01) 3,012,500 30 Restricted shares awards (par value of USD 0.01) (note 11) 399,857 4 48,883,441 489 31 December 2020 No. of shares Par value USD ’000 Common shares (par value of USD 0.01) 45,426,251 455 Earnout shares* (par value of USD 0.01) 3,012,500 30 Restricted shares awards (par value of USD 0.01) (note 11) 134,500 1 48,573,251 486

Share-Based Payments (Tables)

Share-Based Payments (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of share-based payment arrangements [text block] [Abstract]
Schedule of restricted shares awards	Grant date 7 October 2020 First vesting date (tranche 1) 2 January 2021 Second vesting date (tranche 2) 2 January 2022 Third vesting date (tranche 3) 2 January 2023 Total number of restricted shares awards 134,500 Number of restricted shares awards vesting each period 44,833 Grant date fair value (USD) 7.896 Grant date 16 February 2021 First vesting date (tranche 1) 2 January 2022 Second vesting date (tranche 2) 2 January 2023 Third vesting date (tranche 3) 2 January 2024 Total number of restricted shares awards 180,000 Number of restricted shares awards vesting each period 60,000 Grant date fair value (USD) 7.940 Grant date 31 March 2021 First vesting date (tranche 1) 2 January 2022 Second vesting date (tranche 2) 2 January 2023 Third vesting date (tranche 3) 2 January 2024 Total number of restricted shares awards 132,190 Number of restricted shares awards vesting each period 44,063 Grant date fair value (USD) 8.170
Schedule of restricted shares	30 June 31 December Balance at 1 January 134,500 - Restricted shares granted 312,190 134,500 Restricted shares vested (44,833 ) - Restricted shares forfeited (2,000 ) - Balance at end of the period / year 399,857 134,500
Schedule of earnout shares	Grant Days from grant date Earn out shares from first Earn out shares from second Earn out shares from third Total 30 June 2021 30 September 2020 grant 267 1,019 17,324 9,594 27,937 16 February 2021 grant 92 14,582 6,304 4,022 24,908 31 March 2021 grant 135 25,234 11,807 7,707 44,748 Total 40,835 35,435 21,323 97,593 31 December 2020 30 September 2020 grant 88 43,814 8,511 4,714 57,039

Net Investment Income (Tables)

Net Investment Income (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of investment entities [text block] [Abstract]
Schedule of net investment income	For the six months ended 30 June 2021 2020 USD ’000 USD ’000 Interest income 7,742 5,412 Dividends from equities at FVTOCI 43 84 Dividends from equities at FVTPL 456 357 Realized gains and losses on investments Realized loss on sale of bonds at FVTOCI (321 ) (113 ) Realized gain on sale of equities and mutual funds at FVTPL 484 1,639 Unrealized gains and losses on investments Unrealized gain (loss) on revaluation of financial assets at FVTPL 2,128 (2,854 ) Gains and losses from investment properties Realized loss on sale of investment properties (1 ) (41 ) Unrealized loss on investment properties (815 ) (724 ) Rental income 89 84 Expected credit losses on investments Expected credit loss on financial assets at FVOCI (32 ) (65 ) Expected credit loss on financial assets at amortized cost - (1 ) Investments custodian fees and other investments expenses (443 ) (726 ) 9,330 3,052

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of earnings per share [text block] [Abstract]
Schedule of basic and diluted earnings per share	For the six months ended 2021 2020 (Restated) Profit for the period (USD ’000) 18,426 14,507 Less: profit attributable to the Earnout Shares (USD ’000) (1,135 ) (902 ) Less: profit attributable to the restricted shares awards (note 11) (USD ’000) (168 ) - Net profit available to common shareholders (USD ’000) 18,677 13,605 Weighted average number of shares – basic and diluted 45,470,835 40,630,159 Basic and diluted earnings per share (USD) 0.38 0.33

Fair value (Tables)

Fair value (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of fair value measurement [text block] [Abstract]
Schedule of assets and liabilities that are recognized in the financial statements	30 June 2021 Level 1 Level 2 Level 3 Total USD ’000 USD ’000 USD ’000 USD ’000 Assets measured at fair value: FVTPL 25,513 - - 25,513 Quoted equities at FVOCI 17,600 - - 17,600 Quoted bonds at FVOCI 404,026 - - 404,026 Unquoted equities at FVOCI* - - 6,783 6,783 Investment properties - - 18,788 18,788 447,139 - 25,571 472,710 Liabilities measured at fair value: Derivative financial liability 17,423 - - 17,423 31 December 2020 Level 1 Level 2 Level 3 Total USD ’000 USD ’000 USD ’000 USD ’000 Assets measured at fair value: FVTPL 22,780 - - 22,780 Quoted equities at FVOCI 14,935 - - 14,935 Quoted bonds at FVOCI 390,918 - - 390,918 Unquoted equities at FVOCI* - - 6,748 6,748 Investment properties - - 20,012 20,012 428,633 - 26,760 455,393 Liabilities measured at fair value: Derivative financial liability 13,628 - - 13,628
Schedule of reconciliation of fair value of the unquoted equities	30 June 31 December USD ’000 USD ’000 Balance at the beginning of the period / year 6,748 5,794 Purchases - 1,503 Total losses recognized in OCI 35 (549 ) Balance at the end of the period / year 6,783 6,748

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2021
Description of accounting policy for segment reporting [text block] [Abstract]
Schedule of consolidated operations	a) Segment disclosure for the Group’s consolidated operations is as follows: For the period ended 30 June 2021 Specialty Long tail Specialty Short tail Reinsurance Sub Total Corporate and Other Total USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 Underwriting revenues Gross written premiums 101,286 150,930 14,556 266,772 - 266,772 Reinsurer’s share of insurance premiums (26,847 ) (53,231 ) - (80,078 ) - (80,078 ) Net written premiums 74,439 97,699 14,556 186,694 - 186,694 Net change in unearned premiums 8,325 (23,932 ) (3,270 ) (18,877 ) - (18,877 ) Net premiums earned 82,764 73,767 11,286 167,817 - 167,817 Underwriting deductions Net policy acquisition expenses (13,994 ) (13,603 ) (1,792 ) (29,389 ) - (29,389 ) Net claims and claim adjustment expenses (46,176 ) (36,741 ) (6,949 ) (89,866 ) - (89,866 ) Net underwriting results 22,594 23,423 2,545 48,562 - 48,562 General and administrative expenses - - - - (29,284 ) (29,284 ) Net investment income - - - - 9,330 9,330 Share of profit from associates - - - - 258 258 Impairment loss on insurance receivables - - - - (1,121 ) (1,121 ) Other revenues - - - - 1,021 1,021 Other expenses - - - - (1,438 ) (1,438 ) Change in fair value of derivative financial liability - - - - (3,795 ) (3,795 ) Loss on foreign exchange - - - - (3,175 ) (3,175 ) Profit (loss) before tax 22,594 23,423 2,545 48,562 (28,204 ) 20,358 Income tax - - - - (1,932 ) (1,932 ) Profit (loss) for the period 22,594 23,423 2,545 48,562 (30,136 ) 18,426 For the period ended 30 June 2020 Specialty Long tail Specialty Short tail Reinsurance Sub Total Corporate and Other Total USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 USD ’000 Underwriting revenues Gross written premiums 82,986 142,080 11,435 236,501 - 236,501 Reinsurer’s share of insurance premiums (12,455 ) (53,424 ) - (65,879 ) - (65,879 ) Net written premiums 70,531 88,656 11,435 170,622 - 170,622 Net change in unearned premiums (6,133 ) (25,156 ) (3,083 ) (34,372 ) - (34,372 ) Net premiums earned 64,398 63,500 8,352 136,250 - 136,250 Underwriting deductions Net policy acquisition expenses (12,830 ) (11,671 ) (1,369 ) (25,870 ) - (25,870 ) Net claims and claim adjustment expenses (32,105 ) (30,508 ) (1,674 ) (64,287 ) - (64,287 ) Net underwriting results 19,463 21,321 5,309 46,093 - 46,093 General and administrative expenses - - - - (22,423 ) (22,423 ) Net investment income - - - - 3,052 3,052 Share of loss from associates - - - - (439 ) (439 ) Impairment loss on insurance receivables - - - - (2,178 ) (2,178 ) Other revenues - - - - 117 117 Other expenses - - - - (605 ) (605 ) Change in fair value of derivative financial liability - - - - 3,347 3,347 Listing related cost - - - - (3,366 ) (3,366 ) Loss on foreign exchange - - - - (8,658 ) (8,658 ) Profit (loss) before tax 19,463 21,321 5,309 46,093 (31,153 ) 11,593 Income tax - - - - (433 ) (433 ) Profit (loss) for the period (restated) 19,463 21,321 5,309 46,093 (31,586 ) 14,507
Schedule of non-current operating assets information by geography	30 June 31 December USD ’000 USD ’000 Middle East 33,567 34,631 North Africa 357 72 UK 3,199 3,112 Asia 51 75 37,174 37,890

Business Combination (Tables)

Business Combination (Tables)	6 Months Ended
	Jun. 30, 2021
Disclosure of business combinations [text block] [Abstract]
Schedule of common shares issued in Business combination	No. of shares Par value of 0.01 USD USD ’000 Common shares issued to former shareholders of IGI 29,751,444 298 Common shares issued to former stockholders of Tiberius * 15,674,807 157 Unvested shares transferred to certain former shareholders of IGI 1,170,348 12 Unvested Tiberius Founder shares 1,842,152 18 48,438,751 485
Schedule of fair value of the equity instruments	Equity Instruments No. of shares/warrants Fair value per share/warrant Fair value USD USD ’000 Common shares 14,554,807 6.85 99,715 Vested Founder shares subject to a one year lock-up restriction post Business Combination closing date 1,120,000 6.39 7,156 Unvested Tiberius Founder shares 1,842,152 3.48 6,407 Total Value of Consideration 113,278
Schedule of tiberius net assets	Description USD ’000 Cash proceeds received 120,821 Less: liabilities assumed in the form of the Public Warrants (12,750,000 Public Warrants at fair value of USD 0.53 per warrant) (6,807 ) Net assets acquired 114,014
Schedule of difference between the total Value of consideration and cash proceeds received	Description USD ’000 Value of Consideration 113,278 Less: net assets acquired (114,014 ) Bargain (736 )

Basis of Preparation (Details)

Basis of Preparation (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)$ / shares
Disclosure of basis of preparation of financial statements [text block] [Abstract]
Material fair value revaluation loss	5.00%
Recorded against investment properties percentage	9.00%
Description of equity	The correction of this misstatement resulted in a decrease in equity as at 30 June 2020 by USD 5,863 thousand and increase in liabilities with the same amount.
Fair value gains losses (in Dollars) | $	$ 3,347
Basic and diluted earnings per share (in Dollars per share) | $ / shares	$ 0.07

Basis of Preparation (Details)

Basis of Preparation (Details) - Schedule of subsidiaries		6 Months Ended	12 Months Ended
		Jun. 30, 2021	Dec. 31, 2020
International General Insurance Holdings Limited [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		United Arab Emirates
Activity		Reinsurance and insurance
Ownership		100.00%	100.00%
Tiberius Acquisition Corporation [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		United States of America
Activity		Special purpose acquisition company
Ownership		100.00%	100.00%
I.G.I Underwriting /Jordan “Exempted” [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		Jordan
Activity		Underwriting agency
Ownership		100.00%	100.00%
North Star Underwriting Limited [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		United Kingdom
Activity		Underwriting agency
Ownership		100.00%	100.00%
International General Insurance Co. Ltd. [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		Bermuda
Activity		Reinsurance and insurance
Ownership		100.00%	100.00%
International General Insurance Company (UK) Limited [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		United Kingdom
Activity		Reinsurance and insurance
Ownership		100.00%	100.00%
International General Insurance Company (Dubai) Ltd. [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		United Arab Emirates
Activity		Insurance intermediation and insurance management
Ownership		100.00%	100.00%
International General Insurance Company (Europe) SE [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation	[1]	Malta
Activity	[1]	Reinsurance and insurance
Ownership	[1]	100.00%
Specialty Malls Investment Company [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		Jordan
Activity		Real estate properties development and lease
Ownership		100.00%	100.00%
IGI Services Ltd [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		Cayman Islands
Activity		Owning and chartering aircraft
Ownership		100.00%	100.00%
International General Insurance Company Ltd. - Labuan Branch [Member]
Basis of Preparation (Details) - Schedule of subsidiaries [Line Items]
Country of incorporation		Malaysia
Activity		Reinsurance and insurance
Ownership		100.00%	100.00%
[1]	International General Insurance Company (Europe) SE was acquired by the Group on 25 June 2021 (note 20).

Basis of Preparation (Details_2

Basis of Preparation (Details) - Schedule of interim condensed consolidated statements of financial position $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2020USD ($)$ / shares
As previously reported [Member]
Equity:
Warrants	$ 12,213
Share premium	154,225
Retained earnings	193,306
Total equity	366,274
Liabilities:
Derivative financial liability
Total liabilities	800,902
Interim condensed consolidated statement of income
Change in fair value of derivative financial liability
Profit before tax	11,593
Profit for the period	$ 11,160
Basic and dilutive earnings per share (USD) (in Dollars per share) | $ / shares	$ 0.26
Interim condensed consolidated statement of comprehensive income
Total comprehensive income for the period	$ 13,265
Restatement adjustments [Member]
Equity:
Warrants	(12,213)
Share premium	3,003
Retained earnings	3,347
Total equity	(5,863)
Liabilities:
Derivative financial liability	5,863
Total liabilities	5,863
Interim condensed consolidated statement of income
Change in fair value of derivative financial liability	3,347
Profit before tax	3,347
Profit for the period	$ 3,347
Basic and dilutive earnings per share (USD) (in Dollars per share) | $ / shares	$ 0.07
Interim condensed consolidated statement of comprehensive income
Total comprehensive income for the period	$ 3,347
As restated [Member]
Equity:
Warrants
Share premium	157,228
Retained earnings	196,653
Total equity	360,411
Liabilities:
Derivative financial liability	5,863
Total liabilities	806,765
Interim condensed consolidated statement of income
Change in fair value of derivative financial liability	3,347
Profit before tax	14,940
Profit for the period	$ 14,507
Basic and dilutive earnings per share (USD) (in Dollars per share) | $ / shares	$ 0.33
Interim condensed consolidated statement of comprehensive income
Total comprehensive income for the period	$ 16,612

Cash at Banks (Details)

Cash at Banks (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash at Banks (Details) [Line Items]
Cash amount	$ 5,400
US surplus and excess lines business licensed effective			$ 5,400
Deposits	$ 5,000		$ 5,000
Bottom of range [member]
Cash at Banks (Details) [Line Items]
Deposits earned interest, percentage	0.03%
Deposits earned interest, percent			0.20%
Held for varying periods	5 years
Top of range [member]
Cash at Banks (Details) [Line Items]
Deposits earned interest, percentage	4.50%	4.50%
Held for varying periods			5 years

Cash at Banks (Details) - Sched

Cash at Banks (Details) - Schedule of cash and cash equivalents - Cash And Cash Equivalent [Member] - USD ($) $ in Thousands		Jun. 30, 2021	Dec. 31, 2020
Cash at Banks (Details) - Schedule of cash and cash equivalents [Line Items]
Cash and bank balances	[1]	$ 169,033	$ 120,303
Deposits with original maturities of three months or less		11,101	13,136
Total term deposits		$ 180,134	$ 133,439
[1]	This item includes cash in the amount of USD 5,400 thousand placed in a trust account in favor of the National Association of Insurance Commissioners (NAIC) to secure policyholders’ obligations in relation to US surplus and excess lines business licensed effective 1 April 2020 (31 December 2020: USD 5,400 thousand). In addition, this item includes a deposit in the amount of USD 5,000 thousand (31 December 2020: USD 5,000 thousand) placed in favor of the Group as collateral against reinsurance arrangements. The interest earned on this deposit is not recognised as investment income and is transferred to the reinsurance company on a semi-annual basis.

Cash at Banks (Details) - Sch_2

Cash at Banks (Details) - Schedule of term deposits - Term Deposits [Member] - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Cash at Banks (Details) - Schedule of term deposits [Line Items]
Deposits with original maturities over three months and less than one year	$ 152,114	$ 138,510
Deposits with original maturities over one year	33,702	33,702
Total cash and cash equivalents	$ 185,816	$ 172,212

Investments (Details)

Investments (Details) - USD ($) $ in Thousands	6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Investments (Details) [Line Items]
Additional allowances	$ 32
Investments maturity, description		,’ a local company based in Jordan, which had an original maturity date of 22 February 2016.
Investment liquidation, percent		85.00%
Nominal value		$ 1,236
Potential impairment	397
Fair value	3,859
Fair value changes	2,341
Unquoted investment	434		$ 434
Fair value measurement of the unquoted equity investment	6,427	6,504
Bottom of range [member]
Investments (Details) [Line Items]
Implied an equity value	5,778	6,011
Top of range [member]
Investments (Details) [Line Items]
Implied an equity value	7,076	6,997
Unquoted Equity Investments One [member]
Investments (Details) [Line Items]
Designated at fair value through OCI	$ 6,427	6,427	6,314
Unquoted Equity Investment Two [Member]
Investments (Details) [Line Items]
Designated at fair value through OCI		$ 356		$ 434
Unquoted Equity Investments [member]
Investments (Details) [Line Items]
Designated at fair value through OCI			$ 6,314

Investments (Details) - Schedul

Investments (Details) - Schedule of group financial investments - USD ($) $ in Thousands		Jun. 30, 2021	Dec. 31, 2020
Investments (Details) - Schedule of group financial investments [Line Items]
Unquoted bonds	[1]	$ 2,972	$ 3,103
Quoted bonds		404,026	390,918
Quoted funds and alternative investments		11,174	9,791
Quoted equities	[2]	31,939	27,924
Unquoted equities	[3]	6,783	6,748
Expected credit losses and impairment		(397)	(397)
Total		456,497	438,087
Amortized cost [Member]
Investments (Details) - Schedule of group financial investments [Line Items]
Unquoted bonds	[1]	2,972	3,103
Quoted bonds
Quoted funds and alternative investments
Quoted equities	[2]
Unquoted equities	[3]
Expected credit losses and impairment		(397)	(397)
Total		2,575	2,706
Fair value through other comprehensive income [Member]
Investments (Details) - Schedule of group financial investments [Line Items]
Unquoted bonds	[1]
Quoted bonds		404,026	390,918
Quoted funds and alternative investments
Quoted equities	[2]	17,600	14,935
Unquoted equities	[3]	6,783	6,748
Expected credit losses and impairment
Total		428,409	412,601
Fair value through statement of profit or loss [Member]
Investments (Details) - Schedule of group financial investments [Line Items]
Unquoted bonds	[1]
Quoted bonds
Quoted funds and alternative investments		11,174	9,791
Quoted equities	[2]	14,339	12,989
Unquoted equities	[3]
Expected credit losses and impairment
Total		$ 25,513	$ 22,780
[1]	The Group has an investment in an unquoted bond denominated in JOD (USD pegged currency) issued by ‘Specialized Investment Compound Co.,’ a local company based in Jordan, which had an original maturity date of 22 February 2016. However, this company is currently under liquidation, due to which 85% of the original bond holdings with a nominal value amounting to USD 1,236 thousand were not paid on that maturity date.
[2]	In 2020, the Group has sold part of its holdings in a quoted equity at fair value through OCI to take advantage of the increase in the market value of the investee. The quoted equities were purchased in 2011 and held as a long-term investment. Upon disposal, the fair value of the sold shares was USD 3,859 thousand and the cumulative fair value change of USD 2,341 thousand remained in the fair value reserve.
[3]	The Group has two unquoted equity investments under level 3 designated at fair value through OCI valued at USD 6,427 thousand (31 December 2020: USD 6,314 thousand) and USD 356 thousand (31 December 2020: USD 434 thousand).

Investments (Details) - Sched_2

Investments (Details) - Schedule of expected credit losses and impairment provision for the bonds - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Schedule of expected credit losses and impairment provision for the bonds [Abstract]
Opening balance	$ 397	$ 268
Addition of provision for investment in debt securities		129
Ending balance	$ 397	$ 397

Investments (Details) - Sched_3

Investments (Details) - Schedule of fair value of level 3 financial assets - Fair value of Level 3 financial assets [Member] - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2021	Jun. 30, 2020
Investments (Details) - Schedule of fair value of level 3 financial assets [Line Items]
Sensitivity of fair value of financial assets percentage		+/-10	+/-10
Positive impact		$ 676	$ 572
Negative impact		$ (676)	$ (572)
Valuation variables	[1]	Market multiples applied to a range of financial performance measures****	Market multiples applied to a range of financial performance measures****
[1]	As at 30 June 2021, the fair value measurement of the unquoted equity investment valued at USD 6,427 thousand (30 June 2020: USD 6,504 thousand) was based on a combination of valuation multiples, with greater weight given to price to book value multiple. This has implied an equity value range of USD 5,778 thousand to USD 7,076 thousand (30 June 2020: USD 6,011 thousand to USD 6,997 thousand).

Investments in Associates (Deta

Investments in Associates (Details)	6 Months Ended
	Jun. 30, 2021
Descrption Of Accounting Policy For Investments In Associates [Abstract]
Equity ownership interest percentage	32.70%

Investments in Associates (De_2

Investments in Associates (Details) - Schedule of investments in associated companies equity method	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Star Rock SAL Lebanon [Member]
Investments in Associates (Details) - Schedule of investments in associated companies equity method [Line Items]
Country of incorporation	Lebanon
Ownership	32.70%	32.70%
Sina SAL Lebanon [Member]
Investments in Associates (Details) - Schedule of investments in associated companies equity method [Line Items]
Country of incorporation	Lebanon
Ownership	32.70%	32.70%
Silver Rock SAL Lebanon [Member]
Investments in Associates (Details) - Schedule of investments in associated companies equity method [Line Items]
Country of incorporation	Lebanon
Ownership	32.70%	32.70%
Golden Rock SAL Lebanon [Member]
Investments in Associates (Details) - Schedule of investments in associated companies equity method [Line Items]
Country of incorporation	Lebanon
Ownership	32.70%	32.70%

Investments in Associates (De_3

Investments in Associates (Details) - Schedule of movement on investments in associates - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Schedule of movement on investments in associates [Abstract]
Opening balance	$ 11,583	$ 13,062
Share of associated companies’ financial results	35	(79)
Investment properties’ fair value adjustment	(1,091)	(1,902)
Foreign exchange gain arising from revaluation of associated companies	1,314
Reversal of provision for contingent liabilities		502
Share of profit (loss) from associates	258	(1,479)
Ending balance	$ 11,841	$ 11,583

Investments in Associates (De_4

Investments in Associates (Details) - Schedule of financial statements to the change in the price used for the valuation of the investment properties - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Schedule of financial statements to the change in the price used for the valuation of the investment properties [Abstract]
Impact on statement of income percentage	+/- 20	+/- 20
Impact on interim condensed consolidated statement of income for the increase in price per square meter	$ 3,796	$ 2,757
Impact on interim condensed consolidated statement of income for the decrease in price per square meter	$ (3,796)	$ (2,757)

Outstanding Claims (Details) -

Outstanding Claims (Details) - Schedule of movement in outstanding claims - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Gross [Member]
Outstanding Claims (Details) - Schedule of movement in outstanding claims [Line Items]
Reported claims	$ 312,334	$ 292,722
Claims incurred but not reported	179,921	120,331
Reported claims	492,255	413,053
Claims paid	(49,917)	(134,761)
Provided during the period / year related to current accident year	124,862	225,950
Provided during the period / year related to previous accident years	(22,099)	(11,987)
At the end of the period / year	545,101	492,255
Reported claims	325,578	312,334
Claims incurred but not reported	219,523	179,921
Total movement in outstanding claims	545,101	492,255
Reinsurers' share [Member]
Outstanding Claims (Details) - Schedule of movement in outstanding claims [Line Items]
Reported claims	(160,373)	(163,191)
Claims incurred but not reported	(27,112)	(13,021)
Reported claims	(187,485)	(176,212)
Claims paid	13,819	51,018
Provided during the period / year related to current accident year	(33,273)	(68,135)
Provided during the period / year related to previous accident years	20,376	5,844
At the end of the period / year	(186,563)	(187,485)
Reported claims	(143,973)	(160,373)
Claims incurred but not reported	(42,590)	(27,112)
Total movement in outstanding claims	(186,563)	(187,485)
Net [Member]
Outstanding Claims (Details) - Schedule of movement in outstanding claims [Line Items]
Reported claims	151,961	129,531
Claims incurred but not reported	152,809	107,310
Reported claims	304,770	236,841
Claims paid	(36,098)	(83,743)
Provided during the period / year related to current accident year	91,589	157,815
Provided during the period / year related to previous accident years	(1,723)	(6,143)
At the end of the period / year	358,538	304,770
Reported claims	181,605	151,961
Claims incurred but not reported	176,933	152,809
Total movement in outstanding claims	$ 358,538	$ 304,770

Investment Properties (Details)

Investment Properties (Details) - USD ($) $ in Thousands	6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Disclosure of investment property [text block] [Abstract]
Land amount	$ 1,412		$ 1,844
Total carrying value	432	$ 1,277
Recognized loss	$ 1	$ 41

Investment Properties (Detail_2

Investment Properties (Details) - Schedule of investment properties - USD ($) $ in Thousands		6 Months Ended	12 Months Ended
		Jun. 30, 2021	Dec. 31, 2020
Investment Properties (Details) - Schedule of investment properties [Line Items]
Opening balance		$ 20,012	$ 25,712
Additions		23	74
Sale of investment properties		(432)	(3,739)
Fair value adjustment		(815)	(2,007)
Foreign currency adjustment			(28)
Ending balance		18,788	20,012
Commercial building [Member]
Investment Properties (Details) - Schedule of investment properties [Line Items]
Opening balance		18,168	20,063
Additions		23	32
Sale of investment properties
Fair value adjustment		(815)	(1,899)
Foreign currency adjustment			(28)
Ending balance		17,376	18,168
Lands [Member]
Investment Properties (Details) - Schedule of investment properties [Line Items]
Opening balance	[1]	1,844	5,649
Additions	[1]		42
Sale of investment properties	[1]	(432)	(3,739)
Fair value adjustment	[1]		(108)
Foreign currency adjustment	[1]
Ending balance	[1]	$ 1,412	$ 1,844
[1]	Lands amounting to USD 1,412 thousand as at 30 June 2021 (31 December 2020: USD 1,844 thousand) are registered in the name of a former Director. The Group has obtained a proxy and has full control over these investment properties (note 14).

Investment Properties (Detail_3

Investment Properties (Details) - Schedule of change in the price used for the valuation of the investment properties $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)m²	Jun. 30, 2020USD ($)m²
Commercial building [Member]
Investment Properties (Details) - Schedule of change in the price used for the valuation of the investment properties [Line Items]
Percentage of increase decrease in commercial building	+/- 10	+/- 10
Average price per square meter (in Square Meters) | m²	971	1,094
Impact on interim condensed consolidated statement of income for the increase in price per square meter	$ 1,735	$ 1,957
Impact on interim condensed consolidated statement of income for the decrease in price per square meter	$ (1,735)	$ (1,957)
Lands [Member]
Investment Properties (Details) - Schedule of change in the price used for the valuation of the investment properties [Line Items]
Percentage of increase decrease in commercial building	+/- 10	+/- 10
Average price per square meter (in Square Meters) | m²	188	195
Impact on interim condensed consolidated statement of income for the increase in price per square meter	$ 141	$ 419
Impact on interim condensed consolidated statement of income for the decrease in price per square meter	$ (141)	$ (419)

Property, Premises and Equipm_2

Property, Premises and Equipment (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Disclosure of property, plant and equipment [text block] [Abstract]
Additions to property and equipment	$ 267	$ 115
Depreciation expense	634	632
Right-of-use assets for lease	3,101		$ 2,914
Interest expense	91	49
Depreciation expense leased assets	$ 565	$ 278

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Thousands	6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Disclosure of intangible assets [text block] [Abstract]
Addition intaingible assets	$ 1,420	$ 6
Amortization expense	$ 672
Amortization Expense			213 years

Derivative Financial Liabilit_2

Derivative Financial Liability (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)shares
Derivative Financial Liability [Abstract]
Group issued warrants	17,250,000
Warrants Issued to former stockholders	12,750,000
Warrants issued exchange	4,500,000
Warrants transferred	4,000,000
Tiberius warrants transferred	500,000
Change in fair value of derivative financial liability (in Dollars) | $	$ 9,210

Derivative Financial Liabilit_3

Derivative Financial Liability (Details) - Schedule of private warrants - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Schedule of private warrants [Abstract]
Fair value of Warrants at the beginning of the period / Initial recognition of Warrants at the close of the Business Combination - now reclassified from equity to a liability	$ 13,628	$ 9,210
Change in fair value for the period / year	3,795	4,418
Fair value of Warrants at the end of the period / year	$ 17,423	$ 13,628

Common Shares (Details)

Common Shares (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Common Shares (Details) [Line Items]
Cancelled shares	8,555
Shares capital [member]
Common Shares (Details) [Line Items]
Authorized share capital	750,000,000
Par value per share (in Dollars per share)	$ 0.01
Preference shares [member]
Common Shares (Details) [Line Items]
Authorized share capital	100,000,000		1,000
Par value per share (in Dollars per share)	$ 0.01		$ 0.01
Common shares [Member]
Common Shares (Details) [Line Items]
Authorized share capital			1,000
Par value per share (in Dollars per share)			$ 0.01
Increased in shares		48,447,306
Earnout shares [member]
Common Shares (Details) [Line Items]
Authorized share capital		3,012,500
Vesting stock prices at lower range (in Dollars per share)	11.5
Vesting stock price at upper range (in Dollars per share)	$ 15.25

Common Shares (Details) - Sched

Common Shares (Details) - Schedule of number of common shares issued and outstanding - USD ($) $ in Thousands		6 Months Ended	12 Months Ended
		Jun. 30, 2021	Dec. 31, 2020
Common Shares (Details) - Schedule of number of common shares issued and outstanding [Line Items]
Total shares		48,883,441	48,573,251
Total shares (Par value)		$ 489	$ 486
Common shares [Member]
Common Shares (Details) - Schedule of number of common shares issued and outstanding [Line Items]
Common shares		45,471,084	45,426,251
Common shares (Par value)		$ 455	$ 455
Earnout shares [member]
Common Shares (Details) - Schedule of number of common shares issued and outstanding [Line Items]
Earnout shares	[1]	3,012,500	3,012,500
Earnout shares (Par value)	[1]	$ 30	$ 30
Restricted shares awards [Member]
Common Shares (Details) - Schedule of number of common shares issued and outstanding [Line Items]
Restricted shares awards		399,857	134,500
Restricted shares awards (Par value)		$ 4	$ 1
[1]	The Earnout Shares are subject to vesting at stock prices ranges from USD 11.50 to USD 15.25. The Earnout Shares are considered outstanding shares and have dividend and voting rights. However, the Earnout Shares are non-transferable by their holders until they vest and, if the Earnout Shares do not vest on or prior to 17 March 2028, they will be cancelled by the Company.

Share-Based Payments (Details)

Share-Based Payments (Details) - USD ($) $ in Thousands	1 Months Ended			6 Months Ended		12 Months Ended
	Mar. 31, 2021	Feb. 16, 2021	Sep. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Disclosure of share-based payment arrangements [text block] [Abstract]
Restricted shares granted	132,190	180,000	134,500
Earnout shares				97,593		57,039
Share-based payment expense (in Dollars)				$ 779

Share-Based Payments (Details)

Share-Based Payments (Details) - Schedule of restricted shares awards - $ / shares	1 Months Ended
	Mar. 31, 2021	Feb. 16, 2021	Sep. 30, 2020
Schedule of restricted shares awards [Abstract]
Grant date	31 March 2021	16 February 2021	7 October 2020
First vesting date (tranche 1)	2 January 2022	2 January 2022	2 January 2021
Second vesting date (tranche 2)	2 January 2023	2 January 2023	2 January 2022
Third vesting date (tranche 3)	2 January 2024	2 January 2024	2 January 2023
Total number of restricted shares awards	132,190	180,000	134,500
Number of restricted shares awards vesting each period	44,063	60,000	44,833
Grant date fair value (USD)	$ 8.17	$ 7.94	$ 7.896

Share-Based Payments (Details_2

Share-Based Payments (Details) - Schedule of restricted shares - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Schedule of restricted shares [Abstract]
Balance at 1 January	134,500
Restricted shares granted	312,190	134,500
Restricted shares vested	(44,833)
Restricted shares forfeited	(2,000)
Balance at end of the period / year	399,857	134,500

Share-Based Payments (Details_3

Share-Based Payments (Details) - Schedule of earnout shares - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
30 September 2020 grant [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	27,937	57,039
16 February 2021 grant [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	24,908
31 March 2021 grant [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	44,748
Total Earnout Shares [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	97,593
Days from grant date [Member] | 30 September 2020 grant [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	267	88
Days from grant date [Member] | 16 February 2021 grant [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	92
Days from grant date [Member] | 31 March 2021 grant [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	135
Earn out shares from first vesting [Member] | 30 September 2020 grant [Member] | Tranche 1 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	1,019	43,814
Earn out shares from first vesting [Member] | 16 February 2021 grant [Member] | Tranche 1 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	14,582
Earn out shares from first vesting [Member] | 31 March 2021 grant [Member] | Tranche 1 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	25,234
Earn out shares from first vesting [Member] | Total Earnout Shares [Member] | Tranche 1 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	40,835
Earn out shares from second vesting [Member] | 30 September 2020 grant [Member] | Tranche 2 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	17,324	8,511
Earn out shares from second vesting [Member] | 16 February 2021 grant [Member] | Tranche 2 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	6,304
Earn out shares from second vesting [Member] | 31 March 2021 grant [Member] | Tranche 2 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	11,807
Earn out shares from second vesting [Member] | Total Earnout Shares [Member] | Tranche 2 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	35,435
Earn out shares from third vesting [Member] | 30 September 2020 grant [Member] | Tranche 3 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	9,594	4,714
Earn out shares from third vesting [Member] | 16 February 2021 grant [Member] | Tranche 3 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	4,022
Earn out shares from third vesting [Member] | 31 March 2021 grant [Member] | Tranche 3 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	7,707
Earn out shares from third vesting [Member] | Total Earnout Shares [Member] | Tranche 3 [Member]
Share-Based Payments (Details) - Schedule of earnout shares [Line Items]
Earnout shares	21,323

Cash Dividends (Details)

Cash Dividends (Details) $ / shares in Units, $ in Thousands	1 Months Ended
	Mar. 25, 2021USD ($)$ / shares
Disclosure of cash and cash equivalents [text block] [Abstract]
Dividend paid | $	$ 8,288
Dividend per share | $ / shares	$ 0.17

Net Investment Income (Details)

Net Investment Income (Details) - Schedule of net investment income - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Schedule of net investment income [Abstract]
Interest income	$ 7,742	$ 5,412
Dividends from equities at FVTOCI	43	84
Dividends from equities at FVTPL	456	357
Realized gains and losses on investments
Realized loss on sale of bonds at FVTOCI	(321)	(113)
Realized gain on sale of equities and mutual funds at FVTPL	484	1,639
Unrealized gains and losses on investments
Unrealized gain (loss) on revaluation of financial assets at FVTPL	2,128	(2,854)
Gains and losses from investment properties
Realized loss on sale of investment properties	(1)	(41)
Unrealized loss on investment properties	(815)	(724)
Rental income	89	84
Expected credit losses on investments
Expected credit loss on financial assets at FVOCI	(32)	(65)
Expected credit loss on financial assets at amortized cost		(1)
Investments custodian fees and other investments expenses	(443)	(726)
Net investment income	$ 9,330	$ 3,052	[1]
[1]	The consolidated financial statements for the six months ended 30 June 2020 have been restated as per note 2.

Related party transactions (Det

Related party transactions (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Related party transactions (Details) [Line Items]
Salaries and benefits	$ 2,280	$ 2,249
Personnel compensation amount	538	887
Other long term benefits	538
Other long-term employee benefits		887
Aircraft management fees	131	52
Lands total amount	$ 1,412	1,844
Warrants issued (in Shares)	4,000,000
Warrants transferred (in Shares)	4,000,000
Arab Wings Co [Member]
Related party transactions (Details) [Line Items]
Amount payable	$ 181	$ 37
Wasef Jabsheh [Member]
Related party transactions (Details) [Line Items]
Warrants transferred (in Shares)	4,000,000

Earnings Per Share (Details)

Earnings Per Share (Details)	6 Months Ended
	Jun. 30, 2021shares
Disclosure of earnings per share [text block] [Abstract]
Warrants issued	17,250,000
Description of warrants issued	(i) 12,750,000 warrants issued to former stockholders of Tiberius and (ii) 4,500,000 warrants that were issued in exchange for 4,000,000 Tiberius warrants transferred to Wasef Jabsheh and 500,000 Tiberius warrants transferred to Argo Re Ltd., a Bermuda exempted company (note 19).

Earnings Per Share (Details) -

Earnings Per Share (Details) - Schedule of basic and diluted earnings per share - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Schedule of basic and diluted earnings per share [Abstract]
Profit for the period (USD ‘000)	$ 18,426	$ 14,507
Less: profit attributable to the Earnout Shares (note 19) (USD ‘000)	(1,135)	(902)
Less: profit attributable to the restricted shares awards (note 11) (USD ‘000)	(168)
Net profit available to common shareholders (USD ‘000)	$ 18,677	$ 13,605
Weighted average number of shares – basic and diluted (in Shares)	45,470,835	40,630,159
Basic and diluted earnings per share (USD) (in Dollars per share)	$ 0.38	$ 0.33	[1]
[1]	The consolidated financial statements for the six months ended 30 June 2020 have been restated as per note 2.

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	1 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Disclosure of commitments [text block] [Abstract]
Credit amount of insurence contract liabilities	$ 7,994	$ 9,193
Letter of guarantee	321	334
Payment of litigation		$ 5,700
Premiums paid to reinsurers	$ 15,300

Fair value (Details) - Schedule

Fair value (Details) - Schedule of assets and liabilities that are recognized in the financial statements - USD ($) $ in Thousands	6 Months Ended		12 Months Ended
	Jun. 30, 2021		Dec. 31, 2020
Assets measured at fair value:
Fair value	$ 472,710		$ 455,393
FVTPL [Member]
Assets measured at fair value:
Fair value	25,513		22,780
Quoted equities at FVOCI [Member]
Assets measured at fair value:
Fair value	17,600		14,935
Quoted bonds at FVOCI [Member]
Assets measured at fair value:
Fair value	404,026		390,918
Unquoted equities at FVOCI [Member]
Assets measured at fair value:
Fair value	6,783	[1]	6,748
Investment properties [Member]
Assets measured at fair value:
Fair value	18,788		20,012
Derivative financial liability [Member]
Liabilities measured at fair value:
Derivative financial liability	17,423		13,628
Level 1 [Member]
Assets measured at fair value:
Fair value	447,139		428,633
Level 1 [Member] | FVTPL [Member]
Assets measured at fair value:
Fair value	25,513		22,780
Level 1 [Member] | Quoted equities at FVOCI [Member]
Assets measured at fair value:
Fair value	17,600		14,935
Level 1 [Member] | Quoted bonds at FVOCI [Member]
Assets measured at fair value:
Fair value	404,026		390,918
Level 1 [Member] | Unquoted equities at FVOCI [Member]
Assets measured at fair value:
Fair value		[1]
Level 1 [Member] | Investment properties [Member]
Assets measured at fair value:
Fair value
Level 1 [Member] | Derivative financial liability [Member]
Liabilities measured at fair value:
Derivative financial liability	17,423		13,628
Level 2 [Member]
Assets measured at fair value:
Fair value
Level 2 [Member] | FVTPL [Member]
Assets measured at fair value:
Fair value
Level 2 [Member] | Quoted equities at FVOCI [Member]
Assets measured at fair value:
Fair value
Level 2 [Member] | Quoted bonds at FVOCI [Member]
Assets measured at fair value:
Fair value
Level 2 [Member] | Unquoted equities at FVOCI [Member]
Assets measured at fair value:
Fair value		[1]
Level 2 [Member] | Investment properties [Member]
Assets measured at fair value:
Fair value
Level 2 [Member] | Derivative financial liability [Member]
Liabilities measured at fair value:
Derivative financial liability
Level 3 [Member]
Assets measured at fair value:
Fair value	25,571		26,760
Level 3 [Member] | FVTPL [Member]
Assets measured at fair value:
Fair value
Level 3 [Member] | Quoted equities at FVOCI [Member]
Assets measured at fair value:
Fair value
Level 3 [Member] | Quoted bonds at FVOCI [Member]
Assets measured at fair value:
Fair value
Level 3 [Member] | Unquoted equities at FVOCI [Member]
Assets measured at fair value:
Fair value	6,783	[1]	6,748
Level 3 [Member] | Investment properties [Member]
Assets measured at fair value:
Fair value	18,788		20,012
Level 3 [Member] | Derivative financial liability [Member]
Liabilities measured at fair value:
Derivative financial liability
[1]	Reconciliation of fair value of the unquoted equities under level 3 fair value hierarchy is as follows:

Fair value (Details) - Schedu_2

Fair value (Details) - Schedule of reconciliation of fair value of the unquoted equities - Level 3 [Member] - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Fair value (Details) - Schedule of reconciliation of fair value of the unquoted equities [Line Items]
Balance at the beginning of the period / year	$ 6,748	$ 5,794
Purchases		1,503
Total losses recognized in OCI	35	(549)
Balance at the end of the period / year	$ 6,783	$ 6,748

Segment Reporting (Details) - S

Segment Reporting (Details) - Schedule of consolidated operations - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Specialty Long Tail [Member]
Underwriting revenues
Gross written premiums	$ 101,286	$ 82,986
Reinsurer’s share of insurance premiums	(26,847)	(12,455)
Net written premiums	74,439	70,531
Net change in unearned premiums	8,325	(6,133)
Net premiums earned	82,764	64,398
Underwriting deductions
Net policy acquisition expenses	(13,994)	(12,830)
Net claims and claim adjustment expenses	(46,176)	(32,105)
Net underwriting results	22,594	19,463
General and administrative expenses
Net investment income
Share of profit (loss) from associates
Impairment loss on insurance receivables
Other revenues
Other expenses
Change in fair value of derivative financial liability
Listing related cost
Loss on foreign exchange
Profit (loss) before tax	22,594	19,463
Income tax
Profit (loss) for the period	22,594	19,463
Specialty Short tail [Member]
Underwriting revenues
Gross written premiums	150,930	142,080
Reinsurer’s share of insurance premiums	(53,231)	(53,424)
Net written premiums	97,699	88,656
Net change in unearned premiums	(23,932)	(25,156)
Net premiums earned	73,767	63,500
Underwriting deductions
Net policy acquisition expenses	(13,603)	(11,671)
Net claims and claim adjustment expenses	(36,741)	(30,508)
Net underwriting results	23,423	21,321
General and administrative expenses
Net investment income
Share of profit (loss) from associates
Impairment loss on insurance receivables
Other revenues
Other expenses
Change in fair value of derivative financial liability
Listing related cost
Loss on foreign exchange
Profit (loss) before tax	23,423	21,321
Income tax
Profit (loss) for the period	23,423	21,321
Reinsurance [Member]
Underwriting revenues
Gross written premiums	14,556	11,435
Reinsurer’s share of insurance premiums
Net written premiums	14,556	11,435
Net change in unearned premiums	(3,270)	(3,083)
Net premiums earned	11,286	8,352
Underwriting deductions
Net policy acquisition expenses	(1,792)	(1,369)
Net claims and claim adjustment expenses	(6,949)	(1,674)
Net underwriting results	2,545	5,309
General and administrative expenses
Net investment income
Share of profit (loss) from associates
Impairment loss on insurance receivables
Other revenues
Other expenses
Change in fair value of derivative financial liability
Listing related cost
Loss on foreign exchange
Profit (loss) before tax	2,545	5,309
Income tax
Profit (loss) for the period	2,545	5,309
Sub Total [Member]
Underwriting revenues
Gross written premiums	266,772	236,501
Reinsurer’s share of insurance premiums	(80,078)	(65,879)
Net written premiums	186,694	170,622
Net change in unearned premiums	(18,877)	(34,372)
Net premiums earned	167,817	136,250
Underwriting deductions
Net policy acquisition expenses	(29,389)	(25,870)
Net claims and claim adjustment expenses	(89,866)	(64,287)
Net underwriting results	48,562	46,093
General and administrative expenses
Net investment income
Share of profit (loss) from associates
Impairment loss on insurance receivables
Other revenues
Other expenses
Change in fair value of derivative financial liability
Listing related cost
Loss on foreign exchange
Profit (loss) before tax	48,562	46,093
Income tax
Profit (loss) for the period	48,562	46,093
Corporate and Other [Member]
Underwriting revenues
Gross written premiums
Reinsurer’s share of insurance premiums
Net written premiums
Net change in unearned premiums
Net premiums earned
Underwriting deductions
Net policy acquisition expenses
Net claims and claim adjustment expenses
Net underwriting results
General and administrative expenses	(29,284)	(22,423)
Net investment income	9,330	3,052
Share of profit (loss) from associates	258	(439)
Impairment loss on insurance receivables	(1,121)	(2,178)
Other revenues	1,021	117
Other expenses	(1,438)	(605)
Change in fair value of derivative financial liability	(3,795)	3,347
Listing related cost		(3,366)
Loss on foreign exchange	(3,175)	(8,658)
Profit (loss) before tax	(28,204)	(31,153)
Income tax	(1,932)	(433)
Profit (loss) for the period	(30,136)	(31,586)
Total [Member]
Underwriting revenues
Gross written premiums	266,772	236,501
Reinsurer’s share of insurance premiums	(80,078)	(65,879)
Net written premiums	186,694	170,622
Net change in unearned premiums	(18,877)	(34,372)
Net premiums earned	167,817	136,250
Underwriting deductions
Net policy acquisition expenses	(29,389)	(25,870)
Net claims and claim adjustment expenses	(89,866)	(64,287)
Net underwriting results	48,562	46,093
General and administrative expenses	(29,284)	(22,423)
Net investment income	9,330	3,052
Share of profit (loss) from associates	258	(439)
Impairment loss on insurance receivables	(1,121)	(2,178)
Other revenues	1,021	117
Other expenses	(1,438)	(605)
Change in fair value of derivative financial liability	(3,795)	3,347
Listing related cost		(3,366)
Loss on foreign exchange	(3,175)	(8,658)
Profit (loss) before tax	20,358	11,593
Income tax	(1,932)	(433)
Profit (loss) for the period	$ 18,426	$ 14,507

Segment Reporting (Details) -_2

Segment Reporting (Details) - Schedule of non-current operating assets information by geography - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Segment Reporting (Details) - Schedule of non-current operating assets information by geography [Line Items]
Non-current operating assets	$ 37,174	$ 37,890
Middle East [Member]
Segment Reporting (Details) - Schedule of non-current operating assets information by geography [Line Items]
Non-current operating assets	33,567	34,631
North Africa [Member]
Segment Reporting (Details) - Schedule of non-current operating assets information by geography [Line Items]
Non-current operating assets	357	72
UK [Member]
Segment Reporting (Details) - Schedule of non-current operating assets information by geography [Line Items]
Non-current operating assets	3,199	3,112
Asia [Member]
Segment Reporting (Details) - Schedule of non-current operating assets information by geography [Line Items]
Non-current operating assets	$ 51	$ 75

Business Combination (Details)

Business Combination (Details) - USD ($) $ in Thousands	1 Months Ended	6 Months Ended
	Mar. 17, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Business Combination (Details) [Line Items]
Business combination transaction cost		$ 80,000
Business combination, description		Issued (1) 29,759,999 common shares to former shareholders of IGI in exchange for their IGI shares and (2) 18,687,307 common shares to former stockholders of Tiberius, including (I) 9,339,924 common shares issued in exchange for public shares of Tiberius common stock that remained outstanding and not redeemed immediately prior to the closing of the Business Combination, (ii) 4,132,500 common shares issued in exchange for Tiberius founder shares, including 3,012,500 common shares (“Earnout Shares”) subject to vesting at prices ranging from USD 11.50 to USD 15.25 per share, (iii) 2,900,000 common shares issued in exchange for shares of Tiberius common stock that were issued to certain investors in a private placement pursuant to forward purchase agreements, and (iv) 2,314,883 common shares issued in exchange for shares of Tiberius common stock that were issued to certain investors in a private placement.
Description of business combination agreement		In connection with the finalization of the purchase price under the Business Combination Agreement, all escrow shares issued to former shareholders of IGI were released from escrow and 8,555 shares were cancelled. Following the cancellation, the Group has 48,438,751 shares outstanding (including the 3,012,500 unvested shares).
Purchase price shares under business combination (in Shares)		1,170,348
ShareSubjectToBusinessCombinations (in Shares)		1,120,000
Issued		$ 390,232	$ 360,411	$ 381,011	$ 312,143
IGI [Member]
Business Combination (Details) [Line Items]
Business combination of warrants, description	In addition, on 17 March 2020 the Company issued 17,250,000 warrants, including (i) 12,750,000 warrants issued to former stockholders of Tiberius and (ii) 4,500,000 warrants that were issued in exchange for 4,000,000 Tiberius warrants transferred to Wasef Jabsheh and 500,000 Tiberius warrants transferred to Argo Re Ltd.
Incurred listing expenses amount			3,366
Issued capital [member]
Business Combination (Details) [Line Items]
Issued					143,376
Issued capital [member] | Business combinations [member]
Business Combination (Details) [Line Items]
Issued		143,376
Treasury shares [member]
Business Combination (Details) [Line Items]
Issued					$ (20,103)
Treasury shares [member] | Business combinations [member]
Business Combination (Details) [Line Items]
Issued		20,103
Additional Paid-in Capital [Member] | Business combinations [member]
Business Combination (Details) [Line Items]
Issued		$ 2,773

Business Combination (Details)

Business Combination (Details) - Schedule of common shares issued in Business combination $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)shares
Schedule of common shares issued in Business combination [Abstract]
Common shares issued to former shareholders of IGI, Number of shares, | shares	29,751,444
Common shares issued to former shareholders of IGI, Par value | $	$ 298
Common shares issued to former stockholders of Tiberius Number of shares, | shares	15,674,807	[1]
Common shares issued to former stockholders of Tiberius Number of shares, | $	$ 157	[1]
Unvested shares transferred to certain former shareholders of IGI, Number of shares, | shares	1,170,348
Unvested shares transferred to certain former shareholders of IGI, Par value | $	$ 12
Unvested Tiberius Founder shares, Number of shares, | shares	1,842,152
Unvested Tiberius Founder shares, Par value | $	$ 18
Number of shares, total | shares	48,438,751
Par value. total amount | $	$ 485
[1]	This item includes 1,120,000 shares that were subject to a one year lock-up restriction post the closing date of the Business Combination.

Business Combination (Details_2

Business Combination (Details) - Schedule of fair value of the equity instruments	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Schedule of fair value of the equity instruments [Abstract]
Common shares/warrants	14,554,807
Common shares Fair value per share/warrant (in Dollars per share) | $ / shares	$ 6.85
Common shares Fair value	99,715,000
Vested Founder shares subject to a one year lock-up restriction post Business Combination closing date shares/warrants	1,120,000
Vested Founder shares subject to a one year lock-up restriction post Business Combination closing date Fair value per share/warrant (in Dollars per share) | $ / shares	$ 6.39
Vested Founder shares subject to a one year lock-up restriction post Business Combination closing date Fair value	7,156,000
Unvested Tiberius Founder shares shares/warrants	1,842,152
Unvested Tiberius Founder shares Fair value per share/warrant (in Dollars per share) | $ / shares	$ 3.48
Unvested Tiberius Founder shares Fair value	6,407,000
Total Value of Consideration	113,278,000

Business Combination (Details_3

Business Combination (Details) - Schedule of tiberius net assets $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)
Schedule of tiberius net assets [Abstract]
Cash proceeds received	$ 120,821
Less: liabilities assumed in the form of the Public Warrants (12,750,000 Public Warrants at fair value of USD 0.53 per warrant)	(6,807)
Net assets acquired	$ 114,014

Business Combination (Details_4

Business Combination (Details) - Schedule of tiberius net assets (Parentheticals)	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Schedule of tiberius net assets [Abstract]
Public Warrants | shares	12,750,000
Fair value of per warrant | $ / shares	$ 0.53

Business Combination (Details_5

Business Combination (Details) - Schedule of difference between the total Value of consideration and cash proceeds received $ in Thousands	Jun. 30, 2021USD ($)
Schedule of difference between the total Value of consideration and cash proceeds received [Abstract]
Value of Consideration	$ 113,278
Less: net assets acquired	(114,014)
Bargain	$ (736)

Acquisition of a Subsidiary (De

Acquisition of a Subsidiary (Details) - USD ($) $ in Thousands	1 Months Ended	6 Months Ended
	Jun. 25, 2021	Jun. 30, 2021
Acquisition of a Subsidiary (Details) [Line Items]
Voting Percentage		100.00%
Description of business acquisition		As at the Acquisition Date, the book value of the net assets and liabilities of R&Q Epsilon was USD 6,200 thousand consisting of cash at banks of USD 6,054 and the remaining USD 146 thousand represents deferred tax assets and insurance receivables, net of other payable balances.
R&Q Epsilon Insurance Company SE [Member]
Acquisition of a Subsidiary (Details) [Line Items]
Purchase Considetation	$ 6,200